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ABSTRACT 
 
 
Recognition of Mycobacterium tuberculosis by the Host Inflammasome 
 
 
Erin McElvania TeKippe 
(Under the direction of Jenny P-Y. Ting and Miriam Braunstein) 
 
 
 
The NLR gene family mediates host immunity to various acute pathogenic stimuli 
but its role in chronic infection is not known.  This thesis addressed the role of 
NLRP3 (NALP3), its adaptor protein ASC, and caspase-1 during infection with 
Mycobacterium tuberculosis (Mtb).  Mtb infection of macrophages in culture 
induced IL-1β secretion, and this requires the inflammasome components ASC 
(also PYCARD, TMS1), caspase-1, and NLRP3.  However in vivo Mtb aerosol 
infection of Nlrp3-/-, Casp-1-/- , and WT mice showed no differences in pulmonary 
IL-1β production, bacterial burden, or long-term survival.  In contrast, a significant 
role was observed for ASC in host protection during chronic Mtb infection, as 
shown by an abrupt decrease in survival of ASC-/- mice.  Decreased survival of 
Mtb-infected ASC-/- animals was associated with defective granuloma formation 
and reduced CD11c+ CD11bmid/low cells.  ASC is known to bind the non-
inflammasome forming protein Nlrp12in an artificial expression system.  
Following Mtb infection, Nlrp12-/- mice had similar survival, bacterial burden, and 
iv 
cytokine levels compared to the wild-type controls, indicating that Nlrp12 does 
not protect the host during Mtb infection.  These data demonstrate that ASC 
exerts a novel inflammasome-independent role during chronic Mtb infection. 
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CHAPTER 1 
INTRODUCTION 
 
 
Tuberculosis in humans 
 Mycobacterium tuberculosis (Mtb) is the causative agent of the disease 
tuberculosis.  One-third of the world’s population is infected with Mtb, including 9 
million newly infected people and 2 million deaths per year (CDC, 2009).  
Tuberculosis (TB) is an immense health threat of global significance today, but 
the bacterium has also been a human pathogen throughout recorded history.  TB 
was widespread among people of the ancient world.  The earliest evidence of TB 
comes from bone fragments unearthed during archeological excavations dated to 
5000 BC.  Bone deformities indicate that the person had extrapulmonary TB 
(Arriaza et al., 1995).  Due to new DNA sequencing techniques, Mtb DNA has 
been dated from such diverse locations as Egypt, Europe, and pre-Colombian 
North and South America since 2000 BC (Morell, 1994; Nerlich et al., 1997; Salo 
et al., 1994). 
 Before germ theory, there were many ideas for how TB is spread.  The 
Greek philosopher Hippocrates believed children inherited TB from their parents 
since parents with TB tended to have children with TB.  By the Renaissance, an 
2 
association had been drawn between those infected with TB and transmission to 
others via direct contact.  People of the time believed correctly that TB was 
caused by something outside the human body.  In the mid-1800s people with 
active TB infection were quarantined in open-air sanatoriums where fresh air and 
high altitude were used to treat TB.  This method of treatment is not as far-
fetched as it seems.  From a public health standpoint, quarantining infected 
individuals prevents the spread of Mtb to others.  Recent epidemiological studies 
correlate TB susceptibility with low vitamin D levels.  Increased sun exposure is 
one way to elevate the amount of bioavailable vitamin D in the body (Holick et al., 
1980; Liu et al., 2006; Ustianowski et al., 2005).  In the absence of antibiotics, 
sanatoriums were a reasonable way to treat and prevent the spread of TB 
infection.   
 In 1882, Heinrich Hermann Robert Koch uncovered the etiology of TB.  He 
used many techniques he developed including microphotography, cell staining, 
and growth of the organism on solid media to identify and grow Mtb.  Koch 
revealed that Mtb was present in the granulomas of TB patients.  Within the 
granulomas, Mtb was found intracellularly within macrophages (Kaufmann, 
2003).  It was not until 1944, however, that the first chemotherapy for TB became 
available with the identification of streptomycin by Selman A. Waksmann.  
Streptomycin was followed by other anti-tuberculosis drug treatments:  isoniazid 
(1952), pyrazinamide (1954), cycloserine (1955), efhambutol (1962), and 
rifampicin (1963).  Several additional drugs were developed in the years that 
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followed, but unfortunately, no new drugs have been introduced to treat TB in 
decades (Kaufmann, 2008).   
 Standard “short course” therapy for patients diagnosed with active TB is 
treatment with two of the following first-line anti-TB drugs, isoniazid, rifampicin, 
pyrazinamide, and ethambutol, for two months followed by isoniazid and 
rifampicin alone for an additional four months.  Patients with latent TB are treated 
with isoniazid alone for 6-9 months.  More aggressive drug treatment is needed 
to cure children, HIV-infected individuals, and those with drug resistant strains of 
Mtb (CDC, 2009).  Besides the long duration of antibiotic treatment, many drugs 
used to treat Mtb have toxic side effects.  Both of these factors reduce drug 
compliance and increase the chance that patients will develop drug-resistant 
strains of Mtb.  While TB is primarily a disease of the third world, multi-drug 
resistant (MDR) and extensively drug resistant (XDR) strains of Mtb are a 
growing threat worldwide.  MDR strains of Mtb are defined as those resistant to 
at least isoniazid and rifampin.  XDR strains are resistant to isoniazid and 
rifampin plus any fluoroquinolone and at least one of three injectable second-line 
drugs (CDC, 2009).  This makes some XDR TB strains virtually untreatable.  In 
2007, half a million new cases of MDR TB occurred within the year.  Especially 
troubling is the fact that most of these cases had de novo drug resistance and 
were not caused by treatment failure.  XDR TB has been found in 55 countries.  
This is likely an under estimation due to the fact that any third world countries do 
not have the capacity to test for XDR TB.  The magnitude of XDR TB is unknown 
and threatens to bring us back to the days before the development of anti-TB 
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antibiotics (WHO, 2009a).  These statistics on MDR and XDR TB highlight the 
pressing need for new drug treatments which act on different biochemical targets 
or block different stages of the Mtb growth cycle. 
 The first TB vaccine was developed by Albert Calmette, a French 
bacteriologist, and his assistant, Camille Guérin, a veterinarian.  The vaccine was 
based on the successful model of cow pox vaccination used as a vaccine to 
prevent small pox infection.  Unlike cow pox, M. bovis is a virulent human 
pathogen, so Calmette and Guérin grew and passaged the M. bovis on potato 
slices soaked in ox gall to achieve attenuation.  After thirteen years and over 230 
passages, they found that M. bovis was indeed attenuated and named their 
strain M. bovis bacilli Calmette Guérin (BCG).  Calmette and Guérin used animal 
models to validate the vaccine, and in 1921, they vaccinated the first human 
newborn with BCG.  Studies have since shown that the BCG vaccine 
successfully protects against childhood TB.  Unfortunately, it is ineffective against 
the most prevalent form of disease, adult pulmonary tuberculosis (Kaufmann, 
2008; Sterne et al., 1998). 
 At the time of Koch’s discovery, 15 percent of deaths worldwide were 
attributed to TB.  Despite a century of research, the BCG vaccine, and 
antibiotics, in the year 2000 Mtb is still responsible for 4.4 percent of deaths 
worldwide (WHO, 2003).  Of the two billion people infected with Mtb, 90-95 
percent have a latent form of the disease.  The ability to maintain latent infection 
for decades demonstrates that the majority of immunocompetent patients can 
control Mtb infection.  Of those infected only 5-10 percent will develop active 
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disease during their lifetime.  In comparison, immunocompromised patients with 
HIV have a 5-10 percent chance of developing active TB each year.  Latent TB is 
clinically defined as an Mtb infection without symptomatic or other clinical 
evidence of active disease.  Those infected with latent TB have immunological 
evidence of Mtb exposure—either by a positive test for purified protein derivative 
(PPD+) or Mtb-specific interferon-γ (IFN-γ) release assay (IGRA)—along with a 
normal or abnormal but unchanging chest radiograph. 
 The concept of latent TB was first discovered by collecting lymph nodes at 
autopsy from patients that had not shown signs of TB while they were alive.  
After inoculation of the lymph nodes into guinea pigs, twelve percent of the 
guinea pigs developed TB (Loomis, 1890; Wang, 1917).  The same procedure 
was followed with lung tissue from asymptomatic patients and, as seen with the 
lymph nodes, a high percentage of guinea pigs developed TB (Opie, 1927).  
These and many additional studies led scientists to conclude that Mtb is capable 
of persisting in human tissues without causing overt disease.   
 Primary progressive TB—cases in which the patients are infected with Mtb 
and immediately proceed to active TB—is the most common form of the disease 
in children.  In contrast, reactivation of latent TB is the major source of active TB 
in adults.  The causes of reactivation are an area of active investigation, but they 
correlate strongly with age or an immunocompromised health status brought on 
by conditions such as cancer chemotherapy treatment, diabetes, and human 
immunodeficiency virus (HIV).  Mtb and HIV form a co-epidemic that fosters Mtb 
reactivation, faster progression of disease, and increased prevalence of drug-
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resistant strains of Mtb.  Due to these factors, Mtb is the leading cause of death 
among those infected with HIV (WHO, 2009b).  
 The lack of an effective vaccine and new drug treatments caused the 
World Health Organization (WHO) to declare TB a global health emergency in 
1993.  The Stop TB Partnership was formed in 1998 and set forth the following 
goals to eliminate TB worldwide:  [1] by 2005, 70% of people with infectious TB 
will be diagnosed and 85% of those cured, [2] by 2015, the global burden of TB 
disease (deaths and prevalence) will be reduced by 50% relative to 1990 levels, 
and [3] by 2050, the global incidence of TB disease will be less than 1 in a 
million.  The Stop TB Partnership plans to achieve their goals by increasing 
patient access to health care and increasing rates of diagnosis, treatment, and 
cure.  They also advocate the development and implementation of new 
preventive, diagnostic, and therapeutic tools and strategies to stop TB.  The Stop 
TB Partnership hopes that with these strategies TB will be eradicated as a 
human pathogen (WHO, 2010). 
 
Innate immune response to Mycobacterium tuberculosis 
 Mtb is spread from person to person via aerosol.  The lung is constantly 
bombarded with inhaled debris and pathogens, most of which are removed 
through cilliary action of epithelial cells present in the upper airways.  Small 
particles can travel deeper into the lung to the alveolar spaces where they are 
phagocytosed by patrolling alveolar macrophages (Hirsch et al., 1994).  Foreign 
material is taken up into phagosomes which mature and fuse with lysosomes.  
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Inside the lysosome, foreign debris and pathogens are destroyed and degraded.  
Mtb is phagocytosed by alveolar macrophages, but it has defense mechanisms 
that block phagosome-lysosome fusion and this is widely believed to allow the 
bacteria to survive and replicate intracellularly within the macrophage 
phagosome (Brown et al., 1969; Russell, 2007).  
 Infection of alveolar macrophages with Mtb leads to an innate immune 
response.  Toll-like receptors (TLRs) are a family of 11 transmembrane receptors 
that are responsible for some of the innate immune response to pathogens.  
TLRs contain an intracellular Toll/IL-1 receptor (TIR) domain and an extracellular 
leucine rich repeat (LRR) domain (Pasare and Medzhitov, 2005).  TLRs are 
pattern recognition receptors (PRRs) that recognize conserved pathogen-
associated molecular patterns (PAMPs) of bacteria, virus, fungi, and foreign 
DNA.  Members of the TLR family are located on the plasma membrane or within 
endosomes of host immune cells.  During infection, TLRs recognize microbial 
ligands through their LRR domains, initiating recruitment of the adaptor protein 
myeloid differentiation primary response gene 88 (MyD88) which is essential to 
all TLR signaling with the exception of TLR3.  MyD88 is part of a signaling 
cascade involving interleukin-1 receptor-associated kinase 1 (IRAK-1) and TNF 
Receptor Associated Factor 6 (TRAF-6) which results in nuclear factor kappa-
light-chain-enhancer of activated B cells (NFκB) activation and cytokine 
production.  In addition TLR stimulation initiates mitogen-activated protein (MAP) 
kinase and interferon regulatory factor 3 (IRF-3) signaling pathways.  Activation 
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of NFκB and MAPK result in transcriptional changes that effect immunity, mitosis, 
differentiation, proliferation, and cell survival.   
 Mtb contains many known TLR agonists including secreted proteins, 
lipids, and deoxyribonucleic acid (DNA).  Mtb is recognized by TLR2, TLR4, and 
TLR9 in cell culture, but in vivo the results are less clear (Heldwein and Fenton, 
2002; Quesniaux et al., 2004; Stenger and Modlin, 2002).  Human 
polymorphisms in TLR2 are associated with increased susceptibility to Mtb (Ben-
Ali et al., 2004; Ogus et al., 2004).  Mice deficient in TLR9/TLR2 or the TLR 
adaptor MyD88 have drastically reduced survival following Mtb infection (Bafica 
et al., 2005; Feng et al., 2003; Fremond et al., 2004).  These data indicate a clear 
role for TLRs in host defense against Mtb.  However, the individual contributions 
of TLR2 and TLR4 are less clear in a mouse model of Mtb infection, but they may 
play a supporting role in host protection (Abel et al., 2002; Drennan et al., 2004; 
Shim et al., 2003).   
 Cytokine secretion is critical for macrophage activation and recruitment of 
immune cells to the site of infection.  In response to Mtb infection, resting 
macrophages secrete pro-inflammatory cytokines interleukin-1β (IL-1β), tumor 
necrosis factor alpha (TNFα), interleukin-6 (IL-6), and type I interferon (IFN) 
(Kaufmann, 2008).  Mtb-induced secretion of these cytokines results in the 
activation of proximal macrophages.  Activated macrophages provide a less 
conducive intracellular environment for Mtb and therefore are able to limit its 
growth (Chan et al., 1992; Flesch and Kaufmann, 1990; Rook et al., 1986).  
Cytokines are not the only important immune regulators during Mtb infection.  
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IFN-γ induces transcription of nitric oxide synthase (iNOS), which allows the 
generation of reactive nitrogen intermediates (RNI), which contribute to control of 
Mtb growth (Xie et al., 1992).  The culmination of macrophage activation, 
immune cell recruitment, and generation of ROI and RNI ultimately aid in 
controlling Mtb infection. 
  
Host adaptive immune response to Mtb 
 Small animal models are commonly used to study the adaptive immune 
response during Mtb infection.  We utilize a low-dose aerosol method to infect 
mice with Mtb because it mimics the route of human transmission.  During 
aerosol infection, bacteria are taken up by resident alveolar macrophages and 
immature dendritic cells (DCs) in the lungs.  Mtb infection induces macrophages 
and DCs to secrete cytokines and chemokines to recruit inflammatory cells into 
the lung.  During early infection, the majority of immune cells recruited to the lung 
are macrophages and neutrophils.  DCs are antigen-presenting cells that are 
crucial for initiation of the adaptive immune response.  Mtb-infected DCs or those 
that have encountered Mtb proteins migrate from the lung to the draining lymph 
node where they present Mtb antigens to naïve T cells.  Antigen-specific CD4+ T 
cells migrate back to the lung where they secrete interferon-gamma (IFN-γ) and 
activate macrophages to kill intracellular bacteria (Chan et al., 1992; Rook et al., 
1986).  At this stage, the number of lung neutrophils decrease indicating that they 
act primarily as a first line of defense and are only effective during the initial 
phase of infection (Tsai et al., 2006).   
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 Adaptive immunity is critical for control of Mtb.  CD4+ T cells recognize 
Mtb antigens presented by major histocompatibility complex (MHC) class II on 
the surface of antigen-presenting cells.  CD4+ T cells are the dominant adaptive 
immune cell population in the lung during Mtb infections.  Severe combined 
immunodeficiency (SCID) mice that lack functional T and B cells succumb to Mtb 
infection within 5 weeks (Sambandamurthy et al., 2002).  Patients with HIV are at 
high risk of dying from Mtb infection partly because they have reduced CD4+ T 
cells and cannot control bacterial growth during chronic Mtb infection.  In addition 
to production of IFN-γ for macrophage activation, CD4+ T cells also produce 
perforin and granulysin which have cytolytic and microbicidal effects on 
mycobacteria.  Mice lacking CD4+ T cells succumb to Mtb infection sooner than 
wild-type infected mice, but not as quickly as SCID mice (Saunders et al., 2002).  
CD8+ T and natural killer (NK) T cells both produce IFN-γ upon activation and 
may partially compensate for the loss of CD4+ T cells.  These data indicate that 
CD4+ T cells are essential but not sufficient for mounting an effective immune 
response against Mtb.   
 CD8+ T cells are also important for controlling bacteria during the chronic 
phase of Mtb infection.  Upon recognition of Mtb ligands via MHC class I 
presentation, CD8+ T cells are cytolytic through the release of perforin, 
granzymes, and granulysin (Lewinsohn et al., 1998; Ochoa et al., 2001).  Similar 
to CD4+ T cells, CD8+ T cells produce IFN-γ when activated.  CD8+ T cells 
preferentially recognize heavily infected cells while CD4+ T cells do not 
discriminate between lightly and heavily infected cells (Lewinsohn et al., 2003).  
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Similar to CD4+-deficient mice, mice lacking CD8+ T cells succumb to Mtb 
infection sooner than wild-type infected mice, but not as quickly as SCID mice 
(Saunders et al., 2002; van Pinxteren et al., 2000).  This indicates that while both 
CD4+ and CD8+ T cells are important, neither cell type can mount an effective 
adaptive immune response against Mtb alone.  This suggests that other IFN-γ 
producing cells including NK cells compensate for the loss of CD4+ and CD8+ T 
cells.  It is hypothesized that during the early stages of Mtb infection CD4+ T cells 
are important for control and local containment of infection while CD8+ T cells are 
important for granuloma maintenance during chronic infection (Gonzalez-
Juarrero and Orme, 2001; Gonzalez-Juarrero et al., 2001; Tsai et al., 2006).   
 B-cells do not play a prominent role within the granuloma during chronic 
Mtb infection.  B-cells are present during chronic infection, but B cell-deficient 
mice do not succumb to Mtb infection sooner than wild-type mice (Bosio et al., 
2000).  B-cell deficient mice have less severe lung pathology compared to wild-
type mice, and it is hypothesized B cells play a minor role in recruitment and 
retention of lymphocytes during chronic Mtb infection.   
 During human Mtb infection B-cells produce anti-mycobacterial antibodies 
against different groups of antigens depending on the stage of disease.  Mtb-
specific antibody levels are nearly undetectable during the early and latent 
phases of human Mtb infection.  Those present bind Mtb and block bacterial 
binding to mannose receptors, inhibiting bacterial uptake into macrophages 
(Diaz-Silvestre et al., 2005).  There is also evidence that complement is 
important for killing Mtb, as in mice lacking certain complement components are 
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more susceptible to Mtb infection (Daniel et al., 2006).  Upon primary progressive 
TB or reactivation of TB antibody levels rise significantly.  Upon reactivation, the 
host has already been exposed to surface-associated and secreted proteins from 
the initial infection.  Major antigenic proteins are secreted proteins in the Pro-Glu 
(PE)/Pro-Pro-Glu (PPE), and early secretory antigenic target (ESAT) families, 
Antigen 85 (Atg85) complex, and 38 kDa protein as well as heat shock proteins 
and 19 kDa lipoprotein and lipoarabinomannan (LAM) surface proteins (Brightbill 
et al., 1999; Kaufmann, 2008).  The antibody response against active Mtb is 
defined by multiple targets and varies greatly between individuals, making it 
difficult to utilize for diagnostic purposes (Lyashchenko et al., 1998).   
 
Granuloma formation 
 Chronic Mtb infection is controlled by granuloma formation.  A granuloma 
is an organized group of immune cells and extracellular matrix that form around a 
pathogen.  Granulomas occur when the immune system attempts to wall off 
something it senses is foreign, but which it is unable to eliminate.  In this way Mtb 
is contained, but not eliminated within the body (Ulrichs and Kaufmann, 2006).  
Mtb-induced granulomas consist of a central core of infected macrophages 
surrounded by successive waves of activated macrophages, giant multinucleated 
cells, epithelioid cells, T and B cells, fibroblasts and dendritic cells.  A subset of 
granulomas undergo caseous necrosis, a form of biological tissue death results 
in a cheese-like appearance due to proteinaceous dead cell mass present at the 
center of the granuloma.  This is a location hypothesized to be favorable for 
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extracellular Mtb growth (Ulrichs and Kaufmann, 2006).  After Mtb infection, mice 
form granulomas that mimic human granulomas with the exceptions that they do 
not form caseous necrotic centers and are slightly less organized.  In the 
C57BL/6 mouse, CD4+ T cells congregate around infected macrophages, 
initiating the early stages of granuloma formation.  The granuloma is mainly 
comprised of activated macrophages and CD4+ T cells with CD8+ T cells present 
around the periphery of the granuloma.  In the absence of either CD4+ or CD8+ T 
cells, few lymphocytes are recruited to the granuloma with macrophages and 
neutrophils being the dominant cell types.  Dendritic and B cells are also present 
in mouse granulomas during chronic Mtb infections (Rhoades et al., 1997).  DCs 
can be infected by Mtb, but the intracellular environment is not conducive to 
bacterial replication (Gonzalez-Juarrero and Orme, 2001).  DCs are know to 
migrate out of the granuloma and home to the draining lymph node (Schreiber 
and Sandor, 2010).  By this route Mtb infect DCs within the granuloma and use 
them as a Trojan horse to spread infection to other parts of the body.  It is also 
hypothesized that DCs may sample mycobacterial antigens within the 
granulomas and migrate to the draining lymph nodes providing continuous T-cell 
priming (Schreiber and Sandor, 2010).  Granulomas are essential to chronic Mtb 
infection.  They contain Mtb and sequester it from the host immune response, but 
they are unable to eliminate bacteria (Ulrichs and Kaufmann, 2006).  In the 
absence of factors important for granuloma formation and maintenance, 
granuloma integrity is compromised resulting in escape of Mtb and reactivation of 
disease (Flynn et al., 1995). 
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Proinflammatory cytokines and chemokines 
 Cytokines and chemokines are vital to control Mtb infection.  Pro-
inflammatory cytokines are important during the early immune response to Mtb 
as well as for host defense during chronic Mtb infection.  They establish 
gradients which direct migration of inflammatory cells, activate cells, and are vital 
for normal granuloma formation.  In vivo assessments of IL-1α/β-/-, IL-1R-/-, and 
IL-18-/- mice have shown that these cytokines play a role in limiting bacterial lung 
burden, regulating other cytokines, nitric oxide production, and forming organized 
granulomas (Juffermans et al., 2000; Sugawara et al., 2001; Sugawara et al., 
1999).  Likewise, mice deficient in pro-inflammatory cytokines TNFα and IL-6 are 
highly susceptible to Mtb infection, succumbing to infection 30 and 100 days post 
infection, respectively (Bean et al., 1999; Ladel et al., 1997).  TNFα is important 
for granuloma formation and maintenance in the mouse (Flynn et al., 1995).  
Patients treated with anti-TNFα therapies to combat autoimmune diseases have 
a high incidence of TB, indicating that TNFα is important for controlling latent Mtb 
and that in its absence, TB reactivates from latent to active disease (Meya and 
McAdam, 2007; Saliu et al., 2006; Stenger, 2005).  Chemokines also play an 
important role in controlling Mtb infection.  Human TB patients have elevated 
levels of multiple chemokines including monocyte chemotactic protein-1 (MCP-
1), regulated on activation normal T cell expressed and secreted (RANTES), and 
interferon-gamma-induced protein (IP-10) in their blood serum and BAL fluid 
compared to uninfected patients (Algood et al., 2003).  Therefore, cytokine and 
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cytokine regulation are critical to combat Mtb infection during both innate and 
chronic infection.     
 T cell activation by cytokines is important for controlling Mtb during chronic 
infection.  During Mtb infection, macrophages secrete the cytokine IL-12 to recruit 
and activate CD4+ T cells.  Activated T cells secrete IFN-γ which activate 
macrophages.  The cytokines that are involved in positive feedback loop are 
important for control of Mtb infection in mice and humans.  Mice lacking either 
IFN-γ or IL-12 succumb to infection 30-45 days post-Mtb infection (Cooper et al., 
1993; Cooper et al., 1997; Flynn et al., 1993).  Humans and mice with defects in 
the IFN-γ signaling pathway are more susceptible to mycobacterial infections 
(Jouanguy et al., 1999).  This highlights the importance of macrophage and 
CD4+ T cell activation in controlling Mtb infection. 
   
Mtb induction of cell death 
 Macrophages, the primary target of Mtb infection, have been the focus of 
the majority of research on Mtb-induced cell death.  Attenuated strains of 
mycobacteria elicit more macrophage apoptosis than virulent strains (Keane et 
al., 1997).  Additional studies have confirmed that virulent strains of Mtb actively 
suppress macrophage apoptosis by inhibition of TNFα signaling and upregulation 
of host anti-apoptotic proteins (Balcewicz-Sablinska et al., 1998; Sly et al., 2003; 
Spira et al., 2003).  A myriad of studies support a model in which cells undergo 
apoptosis to contain and kill bacteria which benefits the host.  In contrast, cells 
undergo necrosis, which induces bacterial escape from the cell and spread to 
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uninfected cells, therefore benefiting the bacterium (Fratazzi et al., 1997; Keane 
et al., 2000; Lee et al., 2006; Molloy et al., 1994; Oddo et al., 1998; Riendeau 
and Kornfeld, 2003; Velmurugan et al., 2007).  Mice with extreme susceptibility to 
Mtb infection were found to have a susceptibility allele (designated sst1S) within 
the Ipr1 gene (Pan et al., 2005).  Macrophages from mice containing sst1S 
predominantly underwent necrosis, in contrast to mice with a resistant allele 
(sst1R) which primarily undergo apoptosis.  After in vivo Mtb infection sst1S 
containing mice had massive pulmonary necrosis that was absent in sst1R mice.  
These data suggest that apoptosis is a process initiated by the host.  When 
apoptosis is inhibited by Mtb, necrosis predominates. 
  
NLR proteins in immunity 
 The nucleotide-binding domain, leucine rich repeats containing family, 
known as the NLRs, includes genes important in immune regulation, 
inflammation, and autoimmunity.  In 2002, the Ting lab identified a group of 
proteins with similar domain structure to the MHC class II transactivator (CIITA).  
These proteins share a tripartite structure with a variable N-terminal effector 
domain, a central nucleotide-binding domain, and a series of C-terminal leucine-
rich repeats (Ting and Davis, 2005).  A schematic representation of NLR protein 
domains can be found in Figure 1.1.  With the aid of a near complete human 
genome sequence, the lab determined that this family had at least 22 members 
and named it the CARD, transcription enhancer, R(purine)-binding, pyrin, lots of 
leucine repeats, or CATERPILLER gene family (Harton et al., 2002).  Although 
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prior to this others have identified some of the structural domains of this family 
(Martinon et al., 2001; Pawlowski et al., 2001), this report represents the first to 
identify this group of proteins based on structural homology.  Around the same 
time several other research laboratories discovered the same group or partial 
group of proteins (Inohara and Nunez, 2003; Martinon et al., 2001; Pawlowski et 
al., 2001; Tschopp et al., 2003; Wang et al., 2002).  Each gave the proteins a 
different name, leading to confusion within the field.  Standard nomenclature for 
the NLR gene family was implemented in 2008 (Ting et al., 2008a).  Names 
consist of “NLR”, followed by a letter designation for the effector domain of the 
protein.  Because there are multiple NLRs with N-terminal pyrin and CARD 
effector domains, each is followed with a number.  A list of standardized gene 
names and aliases can be found in Table 1.1.   
 NLRs share both functional and structural similarity with plant resistance 
(R) proteins, part of the plant immune system.  Functionally, both NLRs and R 
protein families recognize specific molecules produced by diverse classes of 
pathogens including bacteria, viruses, and fungi.  Structurally, the majority of R 
proteins contain a nucleotide binding domain (NBD) and LRR domain which are 
the two protein domains shared by all NLR proteins.  Each R protein recognizes 
a specific pathogen unlike NLRs which have been shown to recognize multiple 
pathogens.  The plant Arabidopsis has approximately 150 R proteins in its 
genome to accommodate this one-on-one recognition while the promiscuous 
NLR gene family is significantly smaller (Ausubel, 2005; Nimchuk et al., 2001).   
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NLR family proteins and disease associations 
 The initial discovery of NLR proteins was partly due to mutations in these 
genes being associated with human immunological and inflammatory disorders.  
Mutations in CIITA result in a recessive condition called bare lymphocyte 
syndrome.  Patients with this condition do not present MHC class II on the 
surface of antigen-presenting cells.  Consequently, recognition of antigen by T 
cells is impaired leading to a defective adaptive immune response.  Patients with 
bare lymphocyte syndrome have increased susceptibility to pathogens (Ting and 
Davis, 2005).  
 Mutations in human nucleotide-binding oligomerization domain containing 
2 (NOD2) correlate with a subset of patients that develop the inflammatory bowel 
disease, Crohn’s disease (Hugot et al., 2001; Hugot et al., 1996; Ogura et al., 
2001).  Other NOD2 mutations are associated with granulomatous inflammatory 
disorders including early onset sarcoidosis and Blau syndrome (Miceli-Richard et 
al., 2001).  In each case, these mutations lead to impaired immunity in patients 
that are unable to eliminate harmful pathogens (Kobayashi et al., 2005).  In 
addition, NOD1 mutations are linked to increased susceptibility to asthma and 
atopic eczema (Fritz et al., 2006; Geddes et al., 2009). 
 Mutations in NLRP1 and NLRP12 cause autoimmune diseases.  Vitiligo is 
caused by human NLRP1 variants.  Patients with vitiligo have areas of patchy 
depigmented skin caused by the destruction of skin melanocytes.  In addition, 
patients with this disease are at increased risk for other autoimmune diseases 
including rheumatoid arthritis, diabetes, lupus, and thyroid disease (Jin et al., 
19 
2007).  The mechanism by which NLRP1 variants affect skin melanocytes is 
unknown.  Mutations in NLRP12 have been linked to Familial Mediterranean 
Fever, a hereditary inflammatory disorder (Jeru, 2008, PNAS).  A polymorphism 
in NLRP12 has been loosely associated with atopic dermatitis, although it is 
unclear how this intronic polymorphism affects disease pathology (Macaluso et 
al., 2007).   
 In humans, NLRP3 was first identified by its disease association with 
hereditary periodic fever syndromes (Hoffman et al., 2001).  Cryopyrin-
associated periodic syndromes (CAPS) are a group of autoinflammatory 
syndromes caused by autosomal dominant mutations in human NLRP3.  All of 
the 84 known human NLRP3 mutations are located within exon 3, which encodes 
the central NBD.  These gain of function mutations in human NLRP3 cause the 
NLRP3 inflammasome to be activated in the absence of stimulation (Agostini et 
al., 2004; Gattorno et al., 2007).  This result is a hyperinflammatory state due to 
overproduction of active IL-1β within the body in the absence of infection.  CAPS 
encompass a range of disease severity.  At the mild end of the spectrum is 
familial cold autoinflammatory syndrome (FCAS) which presents with fever, cold-
induced urticaria (hives) and mild arthralgia (joint pain) (Hoffman et al., 2001).  At 
the intermediate stage is Muckle-Wells syndrome (MWS) in which patients have 
fever, spontaneous urticaria that is not cold-induced as well as sensorineural 
hearing loss (sensory hearing loss), arthralgia, and sometimes renal amyloidosis 
(Dode et al., 2002).  The most severe form of CAPS is chronic infantile, 
neurological, cutaneous, and articular syndrome (CINCA) also known as 
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neonatal-onset multisystem inflammatory disease (NOMID).  CINCA/NOMID 
patients have deforming arthropathy (joint disease) and chronic aseptic 
meningitis in addition to all the other symptoms of MWS patients (Aksentijevich et 
al., 2002).  CAPS patients are often treated with the IL-1 receptor antagonist 
Anakinran to decrease inflammation (Shinkai et al., 2008). 
  
Inflammasome formation  
 A subset of NLR proteins—NLRP1, NLRP3, NLRC4, and NAIP5—are able 
to form multi-protein complexes known as inflammasomes in response to stimuli 
(Martinon et al., 2002).  When triggered, an inflammasome-forming NLR protein 
comes together to form a multi-protein complex consisting of the adaptor 
molecule apoptotic speck-like protein containing a CARD (ASC) and the inactive 
preprotein pro-caspase-1.  The adaptor molecule ASC contains a N-terminal 
pyrin domain and a C-terminal CARD domain.  This allows ASC to bind the N-
terminal pyrin effector domain of inflammasome-forming NLRs and bind the N-
terminal CARD domain of pro-caspase-1.  Formation of the inflammasome 
results in autocleavage of pro-caspase-1 to its active form.  Caspase-1 then 
recruits inactive forms of the cytokines IL-1β and IL-18 and processes them to 
their active forms (Srinivasula et al., 2002).  These cytokines are then rapidly 
secreted into the extracellular environment where they cause inflammation and 
drive recruitment of cells to the site of infection (Figure 1.2). 
 The functional arrangement of the inflammasome was based on human 
apoptotic protease activating factor 1 (Apaf-1) formation of a multiprotein 
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structure called the apoptosome.  Apaf-1 is not an NLR protein but contains 
similar domain homology to the NLR family.  Apaf-1 contains an N-terminal 
CARD domain and central NBD similar to the NLRs, but has C-terminal WD40 
repeats rather than LRRs.  During times of cellular stress, cytochrome c is 
released from mitochondria and recognized by Apaf-1.  Upon detection, Apaf-1 
monomers come together and form a ringed structure named the apoptosome, 
which is involved in cell apoptosis.  The inflammasome structure is hypothesized 
to form a similar ringed structure consisting of multimers of NLR, ASC, and pro-
caspase-1 proteins (Fritz et al., 2006; Zou et al., 1999). 
 ASC has been associated with apoptosis, cancer, and inflammation.  It 
was discovered as a cytoplasmic protein in promyeloleukemic cell line HL-60 that 
formed an insoluble “speck” during retinoic acid-induced apoptosis (Masumoto et 
al., 1999).  By confocal and electron microscopy, the structure of the ASC speck 
resembles a hollow ball composed of smaller balls and spikes protruding from 
the outer surface (McConnell and Vertino, 2004).  Cloning revealed that ASC is a 
195 amino acid protein consisting of an N-terminal pyrin domain and C-terminal 
CARD domain, the latter of which is characteristic of many apoptosis-signaling 
proteins (Masumoto et al., 1999).   
 A second paper identified the target of methylation-induced silencing 
(TMS1), later identified as ASC, as a protein involved in apoptosis during cancer.  
TMS1 was identified from a screen of genes silenced due to aberrant 
methylation.  TMS1 was aberrantly methylated and silenced in human breast 
cancer cells and these findings were confirmed in forty percent of primary breast 
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tumor samples.  This paper also confirmed a role for TMS1 in apoptosis, 
concluding that aberrant methylation and subsequent gene silencing of TMS1 
promotes breast tumorigenesis by allowing tumor cells to escape from host-
induced apoptosis (Conway et al., 2000).  Further research has shown that 
methylation-induced silencing of TMS1 is not specific to breast cancer, but can 
also be found in a percentage of gastric carcinomas, small cell and non-small cell 
lung carcinomas, malignant melanomas, and primary glioblastomas (McConnell 
and Vertino, 2004).  Aberrant methylation and silencing of TMS1 is cancer 
specific, as corresponding normal tissue lacks TMS1 methylation.  Induced 
expression of ASC has been proposed as a cancer treatment strategy as 
methylation-induced silencing of ASC has caused resistance to p53-mediated 
chemosensitivity (Ohtsuka et al., 2006). 
 ASC is most abundantly expressed in human epithelial cells and 
leukocytes (Masumoto et al., 2001a).  The murine ortholog of ASC (mASC) is a 
193 amino acid protein that with a well conserved N-terminal pyrin and C-
terminal CARD domains with human ASC (hASC).  It has retained a similar 
expression profile as well as the ability to self-associate and aggregate during 
apoptosis similar to hASC and Apaf-1 (Masumoto et al., 2001b).   
 The structure of ASC was used to link the protein to a role in inflammation.  
It was hypothesized that the pyrin and CARD domains of ASC could be sites of 
protein-protein interaction with other proteins containing pyrin and CARD 
domains.  Indeed, ASC was found to associate with NLRP1, NLRP3, NLRP12, 
and NLRP6 through pyrin-pyrin domain interactions (McConnell and Vertino, 
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2004).  Overexpression of ASC with and these individual NLR proteins has been 
linked to increased NFκB activation and apoptosis mediated through the pyrin 
domain.  These studies contained much conflicting data, but the discrepancies 
were thought to be due to differences in expression levels of the overexpressed 
proteins.  To combat the problems caused by overexpression systems, the Ting 
lab used THP-1 cells with reduced expression of ASC by shRNA to show that 
ASC is indeed an activator of NFκB signaling (Taxman et al., 2006).  Other 
studies focused on the CARD domain of ASC.  They found that ASC binds pro-
caspase-1 through CARD-CARD interactions, resulting in caspase-1 activation 
and subsequent processing of pro-IL-1β to its active form (Srinivasula et al., 
2002).  Together these reports revealed that ASC, along with other NLR proteins 
participated in caspase-1 dependent IL-1β cleavage and activation of NFκB 
signaling. 
 Due to high ASC expression in macrophages and myeloid cells, many 
studies have used this cell type to determine the specific stimuli that activate a 
NLR inflammasome.  Martinon et al. used LPS-stimulated THP-1 human 
monocyte cell line for the initial description of the inflammasome.  This report 
found that the inflammasome consisted of a multi-protein complex containing 
ASC, NLRP1, caspase-1, and caspase-5 and that the inflammasome processed 
caspase-1 (Martinon et al., 2002).  Since then ASC has been identified as an 
adaptor protein for several additional NLR proteins that form inflammasomes 
including NLRP3, NLRC4, and NAIP5.  Although it makes sense that the NLR 
proteins with N-terminal CARD domains do not absolutely require ASC for 
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caspase-1 recruitment, the presence of ASC often enhances inflammasome 
activation.  This is the case with NAIP5 and NLRC4 inflammasomes (Ye and 
Ting, 2008).  In addition to these inflammatory functions, ASC association with 
NLR proteins is required for pyroptotic and pyronecrotic cell death (Fernandes-
Alnemri et al., 2007; Ting et al., 2008b).   
 Caspase-1 was originally named IL-1β converting enzyme (ICE) (Cerretti 
et al., 1992).  Caspase-1 is an essential component of all inflammasome 
complexes formed by NLR proteins.  Indicated by its name, caspase-1 regulates 
inflammatory responses by processing pro-inflammatory cytokines IL-1β and IL-
18 from inactive precursor proteins to active cytokines.  IL-1β and IL-18 do not 
contain signal peptides and are secreted from the cell in an unconventional 
manner independent of the Golgi apparatus and endoplasmic reticulum.  
Caspase-1 may be a carrier for secretion of these leaderless cytokines (Keller et 
al., 2008).  In addition to IL-1β and IL-18, a proteomic study has identified over 
70 substrates cleaved by caspase-1 including chaperones, cytoskeletal and 
translation machinery, immune proteins, and components of the glycolysis 
pathway (Keller et al., 2008; Shao et al., 2007).  Although caspase-1 is 
considered an “inflammatory” caspase, it plays a role in apoptotic and pyroptotic 
cell death (Ting et al., 2008b).  Together inflammasome-forming NLRs protect 
the host against PAMPs and danger-associated molecular patterns (DAMPs).    
   
NLRP1 inflammasome 
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 NLRP1 was the first identified inflammasome-forming NLR.  The human 
NLRP1 protein consists of an N-terminal pyrin domain, a central NBD domain, 
and C-terminal LRRs.  The C-terminus of NLRP1 also contains two additional 
domains, a function to find domains (FIIND) and a CARD domain.  The NLRP1 
inflammasome is activated by a small group of identified stimuli including Bacillus 
anthracis lethal toxin and muramyl dipeptide (MDP).  Early studies in human cells 
indicated that the NLRP1 inflammasome consists of NLRP1, ASC, caspase-1, 
and caspase-5.  The NLRP1 inflammasome was the first discovered to involve 
caspase-1 activation (Martinon et al., 2002).  The role of caspase-5 in human 
inflammatory diseases has been difficult to study because it is not present in 
mice.  In the NLRP1 inflammasome, ASC is not essential for NLRP1 
inflammasome activation, but does enhance caspase-1 processing (Faustin et 
al., 2007).  There is some evidence to suggest that NLRP1 and another NLR 
protein, nucleotide oligomerization domain 2 or NOD2, oligomerize in the 
presence of B. anthracis lethal toxin and MDP, although there is nothing to 
suggest either NLR is binding the stimuli directly (Hsu et al., 2008) 
 
NLRC4 inflammasome 
 The NLRC4 inflammasome is stimulated by flagellin and flagellated 
pathogens including Salmonella typhimurium (Franchi et al., 2006; Mariathasan 
et al., 2004; Miao et al., 2006) and Legionella pneumophila (Amer et al., 2006).  
In the case of S. typhimurium cytosolic bacterial flagellin is delivered to the cell 
directly through a type III secretion system (Miao et al., 2006).  Additionall, the 
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NLRC4 is activated by non-flagellated pathogens Shigella flexneri (Suzuki et al., 
2007) and Pseudomonas aeruginosa (Sutterwala et al., 2007). 
 NLRC4 contains a C-terminal CARD domain, a central NBD, and C-
terminal LRRs.  Upon stimulation, the CARD domain of NLRC4 can directly 
associate with the CARD domain of pro-caspase-1 to induce cleavage to active 
caspase-1 (Mariathasan et al., 2004; Poyet et al., 2001).  Although there is no 
direct evidence showing ASC bound to NLRC4, in the absence of ASC, IL-1β 
secretion is impaired in response to many NLRC4-stimulating bacteria 
(Mariathasan et al., 2004; Sutterwala et al., 2007; Suzuki et al., 2007).  This 
indicates that the NLRC4 inflammasome requires ASC or that the bacterial 
pathogens are additionally stimulating another inflammasome forming NLR that 
requires ASC. 
 
NLRP3 inflammasome 
 NLRP3 is the most characterized of all the NLR inflammasome-forming 
proteins.  It is a cytoplasmic protein expressed in macrophages, monocytes, 
granulocytes, dendritic cells, some epithelial cells, osteoblasts, and eroepithelial 
cells (Feldmann, J, 2002, Am J Hum Genet).  Structurally NLRP3 consists of an 
N-terminal pyrin domain, central NBD domain, and C-terminal LRRs.  The pyrin 
domain of NLRP3 allows the protein to bind with other pyrin-containing proteins 
through homotypic pyrin-pyrin interactions.  This is how NLRP3 binds the 
inflammasome adaptor ASC.  The NLRP3 NBD domain is hypothesized to allow 
oligomerization of NLRP3 monomers and inflammasome formation.  The NLRP3 
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LRR domain is hypothesized to function in recognition of PAMPs and DAMPs, 
based on the LRR domain of TLR proteins being the site of PAMP recognition 
(Bell et al., 2003).  How NLRs are sensing pathogens is still unknown, and there 
is no evidence to suggest the LRR domains of NLR proteins are directly 
recognizing pathogens (Pedra et al., 2009).  
 The NLRP3 inflammasome is activated by a broad range of pathogens 
and pathogen products such as LPS, lipooligosaccharide, muramyl dipeptide 
(MDP), nucleic acids, toxins including nigericin from Streptomyces 
hygroscopicus, maitotoxin from murine dinoflagellates, and α-hemolysin 
produced by Staphylococcus aureus.  Additionally, NLRP3 is stimulated by 
cellular danger signals like ATP, uric acid crystals, hyaluronan and heprin sulfate, 
and amyloid-β, as well as environmental dangers such as asbestos, silica, and 
alum adjuvant.  A list of inflammasome activators and references can be found in 
Table 1.2. 
 Reconstitution of the NLRP1 inflammasome revealed that inflammasome 
is activated by a two step process (Faustin et al., 2007).  Signal one functions as 
a priming step to ready the cell for inflammasome activation by activation of 
NFκB signaling.  This results in the upregulation of pro-IL-1β and Nlrp3 
transcripts, necessary for inflammasome function.  TLR signaling is often 
involved in activation of signal one, as it causes potent activation of thee NFκB 
signaling pathway (Bauernfeind et al., 2009).  Only after a specific trigger is the 
inflammasome activated resulting in recruitment and cleavage of caspase-1 and 
subsequent IL-1β activation and secretion (Ghiringhelli et al., 2009).  To prevent 
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aberrant activation of the inflammasome, the presence of multiple checkpoints 
may play a role in limiting inflammasome activation in the absence of a host 
assault.  
 
Other Inflammasome forming NLR proteins 
 Several other NLR proteins are capable of forming inflammasomes when 
stimulated by specific stimuli.  The NLR apoptosis-inhibitory protein 5 (NAIP5) 
contains an N-terminal baculovirus inhibitor of apoptosis repeat (BIR) domain, a 
central NBD, and C-terminal LRRs.  Similar to NLRC4, NAIP5 is a sensor of 
cytoplasmic flagellin.  Co-immunoprecipitation studies have shown that NAIP5 
can associate with NLRC4, indicating they may come together form an 
inflammasome in response to Legonella pneumophilia flagellin (Zamboni et al., 
2006).  NAIP5 does not contain a CARD domain, so it most likely needs NLRC4 
to recruit and process caspase-1 to its active form. 
 Absent in melanoma 2 (AIM-2) is a cytoplasmic protein that functions as a 
double stranded DNA (dsDNA) receptor and activator of antiviral and 
inflammatory responses.  AIM2 is a member of the pyrin and HIN domain-
containing protein (PYHIN) family of proteins.  Although AIM-2 is not an NLR, it 
directly binds dsDNA through its HIN200 domain and associates with ASC 
through its pyrin domain.  This allows AIM2 to activate the inflammasome in the 
absence of an NLR protein.  Upon activation, the AIM2 inflammasome results in 
pro-caspase-1 processing and subsequent IL-1β activation.  Stimulation of AIM2 
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can also activate NFκB signaling (Burckstummer et al., 2009; Fernandes-Alnemri 
et al., 2009; Hornung et al., 2009; Roberts et al., 2009). 
 Very recently, another NLR has been shown to regulate immune signaling 
pathways.  NLRC5 is the largest member of the NLR family with a predicted size 
of 230 kDa.  The Ting lab has identified NLRC5 as a putative inflammasome 
forming protein (Davis and Ting, unpublished data; (Cui et al., 2010).  Two recent 
papers have identified a role for NLRC5 in NFκB and IFN signaling pathways in 
response to viral stimulations.  Currently there is some discrepancy about the 
protein function with one report that NLRC5 is an inhibitor of NFκB and type I IFN 
signaling and the other stating that NLRC5 is a positive regulator of IFN-γ during 
viral infection (Kuenzel, JI, 2010; Cui, Cell, 2010).  It is possible that both reports 
could be correct under different circumstances.  
 
Non-inflammasome forming NLRs 
 A number of NLRs do not form inflammasomes are still associated with 
immune regulation, inflammation, and autoimmunity (Ting et al., 2010).  CIITA is 
expressed constitutively in immune cells where it functions as a transcription 
factor and master regulator of MHC class II expression (Steimle et al., 1994; Ting 
and Trowsdale, 2002).  CIITA is essential to mount an effective adaptive immune 
response against pathogens.  Patients with a loss of function mutations in human 
CIITA have a defective T helper (TH)-dependent immune response (Reith and 
Mach, 2001; Steimle et al., 2007).  CIITA-/- mice cannot limit Mtb growth and they 
succumb to infection approximately 60 days postinfection compared to 300 days 
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postinfection for wild-type mice.  The phenotype of Mtb infected CIITA-/- mice was 
due to a severely depleted CD4+ T-cells and reduced IFN-γ levels (Repique et 
al., 2003).  Although not tested in vivo, one would presume that the reduction in 
INF-γ would result in fewer activated macrophages which are important for 
limiting intracellular Mtb growth.   
 In contrast to the inflammasome-forming NLRs, NLRP12 acts as an anti-
inflammatory NLR in response to stimulation (Williams et al., 2003).  NLRP12 
negatively regulates both the canonical and non-canonical NFκB signaling 
pathways.  During canonical NFκB signaling NLRP12 prevents IRAK-1 hyper-
phosphorylation which dampens NFκB activation (Williams et al., 2005).  In the 
non-canonical NFκB signaling pathway, NLRP12 induces inducing NIK 
degradation which inhibits NFκB activation (Lich et al., 2007).  The inhibitory 
function of NLRP12 is driven by ATP hydrolysis by its central NACHT domain (Ye 
et al., 2008).  In cell culture, NLRP12 is downregulated after stimulation with TLR 
agonists, Mtb, and cytokines TNF-α and IFN-γ (Williams et al., 2005).  This is in 
contrast to the vast majority of studied NLRs which have pro-inflammatory 
functions after PAMP and DAMP stimulation.  However more recent studies 
increasingly show evidence for NLRs that bear negative regulatory functions (Cui 
et al., 2010).  It is hypothesized that downregulation of NLRP12 after pathogen 
exposure allows the host to mount an appropriate immune response.  After the 
pathogen is eliminated, NLRP12 prevents overzealous inflammation and allows 
the cell to return it a resting state in the absence of pathogens. 
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 NLRX1 is a negative regulator of the immune response in response to 
viral stimuli.  The N-terminal X domain of this protein bears similarity to both 
CARD and PYRIN yet can not be categorized either (Moore et al., 2008).  The X 
domain contains a mitochondrial targeting sequence which together with the 
NBD domain is necessary to mediate protein interaction, which confers its 
functional regulatory property.  At the mitochondria, viral ribonucleic acid (RNA) 
induces type I interferon signaling through a signaling pathway involving the 
adaptor protein, mitochondrial antiviral signaling (MAVS).  NLRX1 binds MAVS 
and is a negative regulator of IFN signaling (Moore et al., 2008).  NLRX1 is also 
reported to increase reactive oxygen species in the mitochondria, which amplifies 
NFκB and c-Jun N-terminal kinases (JNK) signaling pathways (Tattoli et al., 
2008). 
 NOD1 and NOD2 are positive regulators of inflammation through 
activation of signaling pathways.  These NLR proteins are cytosolic sensors of 
the bacterial cell wall component peptidoglycan (PGN) (Girardin et al., 2003a; 
Girardin et al., 2003b).  When activated NOD1 and NOD2 upregulate NFκB 
signaling leading to increased pro-inflammatory cytokine production (Chin et al., 
2002).  In addition to NFκB signaling, NOD2 and the adaptor protein CARD9 
upregulate MAPK signaling pathways JNK and p38 (Hsu et al., 2007).  NOD 
proteins have functions beyond PGN recognition.  Recently, NOD2 has been 
implicated in regulation of IRF3 signaling and type I IFN production in response 
to the single-stranded RNA (ssRNA) respiratory syncytial virus (RSV) (Sabbah et 
al., 2009). 
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 The role of NOD2 during both the innate and adaptive immune response 
to Mtb has also been studied.  Mtb-infected macrophages and dendritic cells 
from NOD2-deficient mice have reduced pro-inflammatory cytokines and NO 
compared to wild type.  However, NOD2-/- mice infected with Mtb control bacterial 
growth and survive as long as wild-type mice measured up to eight weeks 
postinfection (Gandotra et al., 2007).  Another paper by Divangahi et al. (year) 
studied NOD2-/- mice during chronic Mtb infection and found that NOD2-/- mice 
have higher lung bacterial burden six months postinfection and reduced survival 
due to impaired T cell function (Divangahi, JI, 2008).  The second paper 
implicates NOD2 in resistance to Mtb infection via the adaptive immune 
response.  This study demonstrates the importance of following Mtb infections 
late into the chronic phase of infection, as the first paper missed the role of 
NOD2 in host protection against Mtb infection. 
 
Summary 
 Immense interest in the role of NLRs in host immunity has led to the study 
of inflammasome complexes in response to many pathogens.  Much of the 
research has been in human monocytic cell lines or in mouse macrophages.  
Chapter 2 of this thesis focuses on the role of the NLRP3 inflammasome during 
Mtb infection in cultured macrophages and in a mouse model.  We find that the 
NLRP3 inflammasome is activated by Mtb in cultured human monocytes and 
primary mouse macrophages.  Because the role of NLR stimulation in one cell 
type is not representative of the role of NLRs in the context of a whole organism, 
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we used a mouse model of Mtb infection to determine the importance of the 
NLRP3 inflammasome in vivo.  We found that in contrast to our in vitro results, 
only murine ASC helps protect the host from death during chronic Mtb infection 
while the effects of Casp-1 and Nlrp3 were negligible.  The mouse model of Mtb 
infection allows us to study the role of the NLRP3 inflammasome during the 
chronic phase of Mtb infection which cannot be modeled in vitro.  Next we 
focused on granuloma formation and immune cells in the lungs during chronic 
infection.  We determined that ASC-/- mice have a decrease in CD11c+ 
CD11bmid/low lung cells and reduced number of lung granulomas compared to 
wild-type lungs.  The inability of ASC-/- mice to form organized granulomas 
indicates a breakdown in host defense against Mtb.  In chapter 3 we investigated 
the role of a non-inflammasome forming NLR, NLRP12, in a mouse model of Mtb 
infection.  NLRP12 has been shown to bind ASC, thus we hypothesized it may 
be important for the host response to Mtb, similar to ASC.  We found that Nlrp12 
did not play a prominent role in host protection against Mtb.  Thus, we identify 
ASC as a critical protein involved in host response to Mtb infection in an 
inflammasome-independent manner. 
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Figure 1.1 Structural domains of NLR proteins 
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Figure 1.2 NLRP3 Inflammasome activation 
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PYCARD; TMS1ASC
NOD9; CLR11.3NLRX1
NALP12; PYPAF7; Monarch1; RNO2; PAN6; 
CLR19.3
NLRP12
CIAS1; PYPAF1; Cryopyrin; CLR1.1; NALP3NLRP3
NALP1; DEFCAP; NAC; CARD7; CLR17.1NLRP1
NOD27; CLR16.1NLRC5
CARD12; CLAN; CLR2.1; IPAFNLRC4
NLRC2; CARD15; CD; BLAU; IBD1; PSORAS1; 
CLR16.3
NOD2
NLRC1; CARD4; CLR7.1NOD1
NLRB1; BIRC1; CLR5.1NAIP
NLRA; MHC2TA; C2TACIITA
 
 
Table 1.1 Standardized NLR names and aliases 
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NLR Stimuli References 
NLRP3 Neisseria gonorrhoeae (Duncan et al., 2009) 
 Listeria monocytogenes Wu et al., 2010; Kim et al., 2010 
 Listeria monocytogenes Kim et al., 2010; Meixenberger et 
al., 2010 
 Streptococcus pyogenes 
streptolysin O 
Harder et al., 2009 
 Klebsiella pneumoniae Willingham et al., 2009 
 Shigella flexneri Willingham et al., 2007 
 Chlamydia trachomatis Abdul-Sater et al., 2009 
 Chlamydia pneumoniae He et al., 2010 
 Aspergillus fumigatus Said-Sadier et al., 2010 
 Candida albicans hyphae Joly et al., 2009 
 Staphylococcus aureus  
α-hemolysin 
Craven et al., 2009; Munoz-Planillo 
et al., 2009 
 Pathogenic Vibrio species Toma et al., 2010 
 Mycobacterium species Koo et al., 2008; Masters et al., 
2008; Mishra et al., 2010; Meyer-
Barber et al., 2010; Carlsson et al., 
2010 
 Porphyromonas gingivalis Huang et al., 2009; Bostanci et al., 
2009 
 Anaplasma 
phagocytophilum 
Pedra et al., 2007 
 Influenza virus Allen et al., 2009; Ichinohe et al., 
2009; Thomas et al., 2009 
 Sendai virus Kanneganti et al., 2006 
 Vaccinia virus Delaloye et al., 2009 
 Malarial hemozoin Shio et al., 2009 
 Fungal zymosan and 
mannan 
Lamkanfi et al., 2009 
 LPS Kanneganti et al., 2006; Sutterwala 
et al., 2006; Martinon et al., 2006 
 MDP Marina-Garcia et al., 2008 
 Viral dsRNA Kanneganti et al., 2006 
 Bacterial RNA Kanneganti et al., 2006 
 Microbial DNA Muruve et al., 2008 
 Nigericin and maitotoxin  Mariathasan et al., 2006 
 ATP Mariathasan et al., 2006 
 Gout-associated crystals Martinon et al., 2006 
 Danger signals Shi et al., 2003 
 Amyloid-β Halle et al., 2008 
 Asbestos and silica Dostert et al., 2008; Perkins et al. 
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 Hyaluronan Scheibner et al., 2006 
 Adjuvents Li et al., 2008; Eisenbarth et al., 
2008  
 Necrosis Li et al., 2009; Iyer et al., 2010 
 Cholesterol-dependent 
cytolysins 
Chu et al., 2009 
NLRC4 Legionella pneumonphila Amer et al., 2006 
 Salmonella typhimurium Amer et al., 2006 
 Shigella felxneri Suzuki et al., 2007 
 Pseudomonas 
aeruginosa 
Miao et al., 2008; Sutterwala et al., 
2007 
 flagellin Miao et al., 2006 
NLRP1 MDP Faustin et al., 2007 
 Bacillus anthracis Hsu et al., 2008 
NAIP5 Legionella pneumonphila Lightfield et al., 2008 
 flagellin Lightfield et al., 2008 
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ABSTRACT 
 The NLR gene family mediates host immunity to various acute pathogenic stimuli 
but its role in chronic infection is not known.  This paper addresses the role of NLRP3 
(NALP3), its adaptor protein ASC, and caspase-1 during infection with Mycobacterium 
tuberculosis (Mtb).  Mtb infection of macrophages in culture induced IL-1β secretion, 
and this requires the inflammasome components ASC (also PYCARD, TMS1), caspase-
1, and NLRP3.  However in vivo Mtb aerosol infection of Nlrp3-/-, Casp-1-/- , and WT 
mice showed no differences in pulmonary IL-1β production, bacterial burden, or long-
term survival.  In contrast, a significant role was observed for ASC in host protection 
during chronic Mtb infection, as shown by an abrupt decrease in survival of ASC-/- mice.  
Decreased survival of ASC-/- animals was associated with defective granuloma 
formation and reduced lung dendritic cell populations.  These data demonstrate that 
ASC exerts a novel inflammasome-independent role during chronic Mtb infection by 
containing the bacteria in granulomas. 
 
INTRODUCTION 
 Mycobacterium tuberculosis (Mtb) is the causative agent of tuberculosis, a 
disease affecting one-third of the world’s population and killing 1.7 million people each 
year (2007).  Mtb is spread by aerosol droplets from persons with active infection.  Upon 
inhalation, Mtb travels to the lung where it infects resident alveolar macrophages 
(Leemans et al., 2001).  This initial infection leads to an innate immune response, which 
includes stimulation of Toll-like receptors (TLRs) that recognize pathogens and are 
located on the plasma membrane and within endosomes of host cells.  Mtb is 
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specifically recognized by TLRs 2, 4, and 9 (Quesniaux et al., 2004).  TLR activation 
upregulates transcription of proinflammatory cytokines interleukin-1β (IL-1β), tumor 
necrosis factor alpha (TNFα), and interleukin-6 (IL-6), which are essential for the 
recruitment of immune cells to the site of infection and controlling Mtb infection (Bean et 
al., 1999; Ladel et al., 1997; Yamada et al., 2000). 
 In addition to TLR recognition a newly discovered class of intracellular danger 
sensing proteins, the nucleotide binding domain, leucine rich repeats-containing family 
proteins known as NLRs, sense pathogens and pathogen products in the cell cytoplasm 
(Ting et al., 2008a).  With more than twenty members, the NLRs function in host 
protection against a broad range of danger signals.  Several NLRs function in immunity 
through the formation of a mutli-protein complex known as an inflammasome (Martinon 
et al., 2002).  When activated by a specific danger signal, the inflammasome forms and 
results in recruitment and processing of pro-caspase-1, which in turn processes IL-1β 
and IL-18 to their active forms for secretion from macrophages. 
 NLRP3 is the most characterized of all the NLR inflammasome-forming proteins 
due to its abundant expression in macrophages and activation in response to the largest 
number of identified stimuli.  In humans, a gain of function mutation in NLRP3 is 
associated with hyperinflammatory hereditary periodic fever syndromes with symptoms 
ranging from mild rash to severe joint swelling (Hoffman et al., 2001).   
 Apoptotic speck-like protein containing a CARD (ASC, also PYCARD) was 
originally identified as a speck-forming protein during apoptosis of HL-60 cells 
(Masumoto et al., 1999).  ASC has also been recognized as an adaptor protein that 
interacts with NLR proteins forming a protein inflammasome structure resulting in 
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caspase-1 processing and subsequent IL-1β and IL-18 activation (Srinivasula et al., 
2002).  ASC has been identified as an adaptor protein for NLRP3 and NLRP1, and it is 
functionally required for the NAIP5 and NLRC4 inflammasomes (Ye and Ting, 2008).  
Each inflammasome responds to a specific set of stimuli, although there is some 
redundancy between NLRs.  Together, ASC, NLRP3, and caspase-1 are essential for 
macrophage IL-1β maturation in response to a broad range of stimuli including bacteria 
(Mariathasan et al., 2006; Willingham et al., 2007) and viruses (Allen et al., 2009; 
Ichinohe et al., 2009; Kanneganti et al., 2006; Muruve et al., 2008).  In addition to these 
inflammatory functions, ASC association with NLR proteins is required for pyroptotic 
and pyronecrotic cell death (Fernandes-Alnemri et al., 2007; Ting et al., 2008b).  
Although the host’s innate immune response to Mtb infection is critical for the initial 
defense against bacteria, the adaptive immune response is ultimately required for 
containment of the infection in the chronic stage of disease.  Adaptive immunity to Mtb 
infection is characterized by the appearance of antigen specific CD4+ T-cells that 
secrete interferon-gamma (IFN-γ), which is responsible for activating macrophages to 
kill intracellular bacteria (Chan et al., 1992).  CD8+ T-cells are also important for 
controlling bacteria during the chronic phase of Mtb infection (van Pinxteren et al., 
2000).  Chronic Mtb infection is controlled by granuloma formation which contains, but 
does not eliminate bacteria (Ulrichs and Kaufmann, 2006).  Granulomas consist of a 
central core of Mtb-infected macrophages surrounded by successive waves of activated 
macrophages, giant multinucleated cells, epithelioid cells, lymphocytes, fibroblasts and 
dendritic cells.  A subset of granulomas undergoes central caseous necrosis due to 
proteinaceous dead cell mass.  Mice form slightly different granulomas that do not form 
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caseous necrotic centers, but otherwise possess the same cell types and similar 
granuloma organization to humans (Rhoades et al., 1997). 
 Pro-inflammatory cytokine regulation can be critical to long-term survival of Mtb 
infection.  In vivo assessments of IL-1α/β-/-, IL-1R-/-, and IL-18-/- mice have shown that 
these cytokines play a role in limiting bacterial lung burden, regulating other cytokines, 
nitric oxide production, and forming organized granulomas (Juffermans et al., 2000; 
Sugawara et al., 2001; Sugawara et al., 1999).  Likewise, mice deficient in pro-
inflammatory cytokines IL-6 and TNFα have increased mortality during Mtb infection 
(Bean et al., 1999; Ladel et al., 1997).  TNFα is important for granuloma formation and 
maintenance (Flynn et al., 1995).  Therefore, these cytokines are not only important in 
the innate immune response to Mtb, but also in host defense during chronic Mtb 
infection. 
 High interest in the role of NLRs in host immunity has led to the study of 
inflammasome complexes in response to many pathogens.  The research thus far has 
almost exclusively focused on the acute effects of pathogens and other NLR stimuli.  
Consequently, the in vivo role of the NLR inflammasome during chronic infection has 
not been studied.  Mtb infection exemplifies a chronic infection of paramount public 
health interest.  Mtb infects macrophages where it must thwart the host immune 
response to survive and replicate.  Nlrp3 inflammasome proteins are expressed in 
macrophages, thus we hypothesized that Mtb infection would induce inflammasome 
activation.  Here we show that Mtb induced IL-1β secretion in human and mouse 
macrophages in vitro and this process was dependent on ASC, caspase-1, and NLRP3, 
but not NLCR4.  In vivo, murine ASC helps protect the host from death during chronic 
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Mtb infection while the effects of Casp-1 and Nlrp3 were negligible.  The inability of 
ASC-/- mice to form organized granulomas and the reduced presence of lung dendritic 
cells indicates a breakdown in host defense against Mtb.  Thus, we identify ASC as a 
critical protein involved in host response to Mtb infection in an inflammasome-
independent manner. 
 
RESULTS 
Virulent and attenuated Mtb require ASC, NLRP3, and caspase-1 for IL-1β 
secretion by cultured human cells 
 During human Mtb infection, bacteria travel to the alveolar spaces where they 
infect and replicate inside macrophages.  Secretion of IL-1β by macrophages requires 
pro-IL-1β processing by caspase-1.  Caspase-1 interaction with several NLR forming 
inflammasomes results in caspase-1 processing, a prerequisite for IL-1β activation (Ye 
and Ting, 2008).  To determine if host detection of Mtb involves inflammasome 
activation, we used a used a panel of human monocytic THP-1 cell lines with reduced 
expression of inflammasome genes due to shRNA targeting sequences (Table 2.1, 
Figure 2.1).  During infection with the virulent Mtb strain H37Rv, THP-1 cells with 
shASC or shNLRP3 secreted significantly less IL-1β than their scrambled controls 
(Figure 2.2 A).  This indicates that Mtb activates the NLRP3 inflammasome.  IL-18 is an 
inflammatory cytokine which induces cell-mediated immunity and causes T-cells to 
secrete IFN-γ (Okamura et al., 1995).  Similar to IL-1β, it also requires caspase-1 
cleavage for activation.  IL-18 secretion from Mtb infected THP-1 cells was dependent 
on ASC and NLRP3 (Figure 2.2 B).  These data demonstrated that both IL-1β and IL-
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18 were processed during Mtb infection and that each required the NLRP3 
inflammasome formation for activation in the THP-1 human monocytic cell line. 
 As seen with H37Rv, the attenuated Mtb H37Ra strain induced IL-1β secretion 
from THP-1 cells in a ASC- and NLRP3-dependent manner.  Induction of IL-1β by 
H37Ra was dependent on the NLRP3 inflammasome (Figure 2.2 C).  We consistently 
see more IL-1β secretion in THP-1 cells infected with H37Ra, although the difference is 
not statistically significant.  Thus, the NLRP3 inflammasome is activated by both virulent 
and attenuated Mtb.  Chemically inhibiting caspase-1 with caspase-1-specific inhibitor 
Y-VAD significantly reduced IL-1β secreted by THP-1 cells, confirming the necessity of 
caspase-1 cleavage for IL-1β secretion (Figure 2.2 D). 
 
Production of IL-1β in Mtb infected primary mouse macrophages is ASC, Nlrp3, 
and Casp-1 dependent 
 To confirm our THP-1 data that the inflammasome is necessary for IL-1β 
processing, we infected primary mouse macrophages from gene depletion mice.  We 
infected either bone-marrow derived (BMDM) or thioglycolated elicited macrophages 
with Mtb.  Mtb induced IL-1β secretion in wild type macrophages, confirming the results 
we obtained with THP-1 cells.  Mtb infected BMDM from ASC-/-, Nlrp3-/-, and Casp-1-/- 
mice had significantly reduced IL-1β secretion, indicating that the Nlrp3-inflammasome 
is necessary for Mtb induced IL-1β secretion in macrophages.  Nlrc4-/- BMDM secreted 
IL-1β at the same or higher levels compared to wild type, indicating this inflammasome 
is not involved in the host response to Mtb (Figure 2.3 A).  This demonstrates 
congruent findings using THP-1 cells and primary mouse macrophages. 
62 
 Induction of the NLRP3 inflammasome was not limited to virulent Mtb H37Rv 
infection, but also occurred with attenuated Mtb H37Ra (Figure 2.3 B).  Wild type 
BMDM infected with Mtb H37Ra secreted abundant amounts of IL-1β while ASC-/- and 
Nlrp3-/- macrophages did not.  Our findings were repeated in primary thioglycolate 
elicited macrophages.  These highly activated macrophages had a significant reduction 
in IL-1β secretion in the absence of ASC and Nlrp3 (Figure 2.3 C), reinforcing our data 
from human THP-1 cells and BMDM infected with virulent and attenuated Mtb.  IL-18 
secretion from both BMDM and thioglycolate elicited macrophages was below the level 
of detection for all samples tested.  Taken together, our data show that the ability of Mtb 
to induce IL-1β secretion was ASC, NLRP3, and caspase-1 dependent in human THP-1 
cells as well as primary mouse macrophages.  In contrast, NLRC4 did not affect IL-1β 
production, indicating that Mtb induces a host response through the NLRP3, but not the 
NLRC4, inflammasome. 
 
ASC but not Nlrp3 protects the host against virulent Mtb infection 
 Lack of IL-1β in vivo has been previously shown to be important for response to 
Mtb infection resulting in increased lung bacterial burden, differential regulation of 
cytokines, and defects in granuloma formation (Sugawara et al., 2001; Yamada et al., 
2000).  Given our data from infecting cultured cells, we hypothesized that mice lacking 
the ASC or Nlrp3 would be unable to process IL-1β resulting in an inability to control 
Mtb in vivo.  To test this hypothesis, wild type, ASC-/-, and Nlrp3-/- animals were infected 
with aerosolized Mtb H37Rv.  Each mouse received between 250-350 cfu per lung.  
During the first four-and-a-half months, survival of wild type and ASC-/- mice was similar.  
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However, ASC-/- mice had a survival defect thereafter and they died precipitously 
between 130 and 142 days postinfection with a mean survival of 137 days (Figure 2.4 
A).  By comparison, wild type mice infected with Mtb had a mean survival of 214 days.  
These results were confirmed in a second (Figure 2.4 B) and third experiment (not 
shown).  Death of ASC-/- mice during Mtb infection was not due to advanced age as we 
routinely keep ASC-/- breeder pairs for up to a year with no unexplained deaths.  This 
strong survival phenotype shows that ASC is important for host defense against virulent 
Mtb infection in vivo. 
 ASC is an adaptor protein that is required for several NLR proteins to form 
inflammasomes.  Since our in vitro data indicated NLRP3 was necessary for Mtb 
induction of IL-1β in macrophages, we also investigated survival of Nlrp3-/- mice during 
aerosolized Mtb infection.  Although NLRP3 is important for IL-1β secretion from 
cultured macrophages, there was no difference in survival of Nlrp3-/- mice in vivo 
(Figure 2.4 C).  Overall, Nlrp3-/- mice had a mean survival of 211 days compared to 214 
days for wild type mice.  This data was also confirmed in a second experiment (Figure 
2.4 D).  In a separate experiment, we tested the ability of another closely related NLR 
gene, Nlrc4, to protect the host from Mtb.  Nlrc4-/- mice had a similar survival profile to 
paired wild type controls, with a mean survival of 190 days compared to 198 days for 
wild type controls (Figure 2.4 E).  These data indicate that elimination of ASC, but not 
Nlrp3 nor Nlrc4, resulted in a reduced ability of the host to defend against Mtb infection. 
 
ASC and Nlrp3 do not significantly affect Mtb bacterial burden 
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 Prior in vivo studies show that Mtb has two phases of infection (Orme, 1994).  In 
the first three weeks following aerosol infection Mtb grows logarithmically in the lungs.  
After three weeks of infection, an effective TH1 adaptive immune response is 
established and the exponential growth of Mtb ends.  Mtb bacterial burden in the lungs, 
spleen, and liver persist at the same level for the remainder of the infection (Kaufmann, 
2008).  We assessed bacterial burden in the lungs of ASC-/- and Nlrp3-/- mice in two 
separate infections, with each compared to paired C57BL/6 controls.  Animals lacking 
ASC and Nlrp3 have similar levels of bacteria in the lungs during the growth and 
persistence phases of Mtb infection compared to wild type (Figure 2.5 A, B).  The last 
time points were taken as ASC-/- and Nlrp3-/- mice neared death.  We saw no statistical 
difference between the bacterial burden of lungs from ASC-/-, Nlrp3-/- , or wild type mice.  
The bacterial burden in the liver and spleen of the ASC-/- and Nlrp3-/- mice was also 
similar to that found in wild type mice, indicating that ASC and Nlrp3 do not affect 
bacterial dissemination (Figure 2.5 C-F).  Thus a change in bacterial burden and 
dissemination cannot explain the different survival rate of ASC-/- compared to WT or 
Nlrp3-/- mice. 
 
Pro-inflammatory cytokines are produced at similar levels in the lungs of wild 
type, ASC-/-, and Nlrp3-/- mice following Mtb H37Rv aerosol infection 
 Our earlier studies led us to hypothesize that less IL-1β would be produced in the 
lungs of ASC-/- and Nlrp3-/- mice compared to wild type because the gene deletion mice 
would not be able to cleave pro-IL-1β to its active form in response to Mtb infection.  To 
test this, cytokines were measured from tissue free homogenized lung extract by 
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enzyme-linked immunosorbent assay (ELISA).  Surprisingly, we found all three groups 
of animals produced IL-1β in similar amounts.  IL-1β levels increased during the 
logarithmic growth phase of infection and were still high during the persistence phase of 
infection (Figure 2.6 A).  By week 16, levels of IL-1β decreased slightly.  There was no 
significant reduction in IL-1β secretion between ASC-/- and Nrp3-/- mice compared to 
wild type at any of the time points we measured.  Because of the mechanical nature of 
lung homogenization, cells are broken open in the process which could result in release 
of both pro and cleaved IL-1β in the lung homogenate extracts.  We performed IL-1β 
western blots in addition to ELISAs to ensure we were measuring the amount of cleaved 
IL-1β produced in the lungs of Mtb-infected animals in vivo.  At one week postinfection, 
as expected, only pro-IL1β was present (Figure 2.6 B, top panel).  At 16 weeks 
postinfection, ASC-/- and Nlrp3-/- animals produced comparable if not enhanced levels of 
cleaved IL-1β compared to wild type mice (Figure 2.6 B, bottom panel).  The amount 
of IL-1β was reproducible between mice of the same genotype and correlates with the 
ELISA data.  These data show that differences in IL-1β production cannot explain 
differences in the survival rate of ASC-/- compared to WT or Nlrp3-/- animals.  We also 
measured pro-inflammatory cytokines IL-6 and TNFα.  TNFα is of particular interest as it 
is important for granuloma formation and the control of infection in Mtb-infected animals 
and humans (Bean et al., 1999; Flynn et al., 1995).  IL-6 has also been shown to be an 
important host response against Mtb (Ladel et al., 1997).  Furthermore, a previous 
report showed that human ASC is required for TNFα and IL-6 expression upon bacterial 
infection (Taxman et al., 2006).  Both cytokines followed similar trends as IL-1β with 
total cytokine levels rising during early infection and then dropping off significantly by 
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week 16 (Figure 2.6 C, D).  Nlrp3-/- mice had a modest but statistically significantly 
increase in IL-6 and TNF-α cytokines at 2 weeks (p=0.026 and p=0.028, respectively) 
and 5 weeks postinfection (p=0.004, p=0.001, respectively), but all differences were 
diminished by 16 weeks postinfection.  There were no significant differences in lung 
cytokine levels between ASC-/- and wild type mice at any time points analyzed.  
Proinflammatory cytokines in serum and bronchoalveolar lavage fluid were below the 
level of detection.  These data indicate that reduced TNFα and IL-6 are not correlated 
with increased death in Mtb-infected ASC-/- mice. 
 
Caspase-1 is not required for survival, bacterial containment, or the production of 
proinflammatory cytokines in Mtb infected mice 
 Caspase-1 recruits and cleaves IL-1β to its active form and is common to all NLR 
inflammasomes.  A previous report has shown that at a low infectious unit of influenza 
virus, viral-induced host response is mediated by an Nlrp3-independent but ASC/Casp-
1-dependent inflammasome (Ichinohe et al., 2009). To assess if Caspase-1 and ASC 
together mediate host protection in the context of inflammasome activation, we 
investigated the contribution of Caspase-1 during Mtb infection.  Infection of Casp-1-/- 
mice with Mtb produced no difference in survival compared to wild type mice (Figure 
2.7 A).  Measurement of bacterial burden showed that Casp-1-/- and wild type mice had 
similar levels of bacteria in the lungs over the course of Mtb infection (Figure 2.7 B).  
Casp-1-/- and wild type mice also had similar bacterial burden in the liver and spleen, 
indicating that bacterial dissemination and growth in these organs are comparable 
between genotypes (Figure 2.7 C).  Overall, these data indicate that Caspase-1 does 
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not play a prominent role in host protection during Mtb infection.  Hence this work 
describes a novel ASC-dependent but Casp-1-independent form of host immunity. 
 Caspase-1 cleaves pro-IL-1β to its biologically active form, however our earlier 
results demonstrated that cleaved IL-1β levels were similar in ASC-/-, Nlrp3-/-, and Nlrc4-
/- lungs.  An analysis of Casp-1-/- mice show that rather than diminished IL-1β, they had 
increased lung IL-1β in their lungs compared to wild type as measured by ELISA 
(Figure 2.8 A).  We utilized Western blots to measure both the pro- and cleaved forms 
of IL-1β from lung homogenate extracts collected one week and 20 weeks post 
infection.  At one week post infection only low levels of pro-IL-1β were present in the 
Casp-1-/- and wild type lungs (Figure 2.8 B, top panel).  At 20 weeks post infection pro- 
and cleaved IL-1β were present in both Casp-1-/- and wild type mouse lungs with more 
found in the former (Figure 2.8 B, bottom panel).  These data demonstrate that Casp-
1-/- mice have compensatory mechanisms of cleaving IL-1β in the absence of caspase-
1.  Levels of IL-6 and TNF-α also were unchanged between Casp-1-/- and wild type 
lungs (Figure 2.8 C-D).  Overall our in vivo characterization of the Casp-1-/- mouse 
reveals that Caspase-1 does not play a prominent role in host protection against Mtb.  
This supports the conclusion that protective host immunity to Mtb is independent of the 
inflammasome. 
 
ASC-/- macrophages show a modest reduction of signal transduction 
 ASC has been associated with NFκB and AP1 signaling independent of NLRP3 
or caspase-1 function (Hasegawa et al., 2009; Stehlik et al., 2002; Taxman et al., 2006).  
To determine if NFκB activation is affected in the absence of ASC we infected BMDM 
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with Mtb and assessed phosphorylation of nuclear factor of kappa light polypeptide 
gene enhancer in B-cells inhibitor, alpha (IκBα) and NFκB p65.  In all cases we saw 
modest but reproducible decreases in NFκB signaling proteins in the ASC-/- 
macrophages compared to wild type macrophages.  We also measured activation of 
MAP kinases extracellular-signal-regulated kinases (ERK), JNK, and p38 which are 
known to be upregulated during Mtb infection (Roach and Schorey, 2002).  We found 
that ERK and JNK phosphorylation was modestly decreased in ASC-/- macrophages 
compared to wild type, but p38 showed no reduction in activation (Figure 2.9). 
 
ASC-/- mice have functional T-cells, but a reduced CD11c+ CD11bmid/low lung cell 
population during chronic Mtb infection 
 T-cell function is essential to mount an adaptive immune response against Mtb.  
We collected lymphoid cells from wild type and ASC-/- mice infected with Mtb for 95 
days and identified the cell populations by flow cytometry.  Overall, ASC-/- mice had 
higher percentages of CD4+ and CD8+ T-cells in their lung, spleen, and mediastinal 
lymph node (MLN) (Figure 6A-F).  To test T-cell function, we measured the ability of T-
cells from Mtb infected mice to be activated by a general CD3/CD28 stimulation or Mtb–
specific PPD, shown by production of intracellular IFN-γ.  In all organs tested inherent 
T-cell function in ASC-/- mice was comparable to wild type after 5 hours of stimulation 
(Figure 2.10 A-F).  The total number of cells recovered from each organ was equivalent 
between ASC-/- and wild type mice (Figure 2.11 A).  These data indicate that T-cells are 
not the cause of ASC-/- susceptibility to Mtb infection.  To further explore the mechanism 
by which ASC enhances survival, we investigated myeloid cell populations present in 
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the lungs of chronically infected mice.  ASC-/- mice have a significantly reduced CD11c+ 
CD11bmid/low cell population compared to wile type mice (p=0.000015) (Figure 2.11 B-
C).  During the chronic phase of infection CD11c+ cells are located in both human and 
mouse granulomas, present from 2 weeks post infection and progressively increasing 
over the course of infection (Tsai et al., 2006; Uehira et al., 2002).  Reduced dendritic 
cells in the lungs of ASC-/- provide plausible mechanisms to explain the decreased 
lifespan observed in these animals during chronic Mtb infection. 
 
ASC-/- mice have increased GR1+ lung cell population during chronic Mtb infection
 Following whole lung digest of mice infected with Mtb for 95 days, we found an 
increased percentage of GR1+ cells in the lungs of ASC-/- mice when compared to wild-
type controls (Figure 2.12 A-B).  GR1+ cells, which are classically defined as 
neutrophils, are recruited to the lungs of wild type mice during initial infection, peaking at 
two weeks post infection, after which the number of neutrophils decline (Kaufmann, 
2008).  It is unusual for neutrophils to be present within the granuloma during chronic 
infection.  We found that wild-type lungs contain approximately one percent of GR1+ 
cells during chronic Mtb infection (Figure 2.12 A-B).  Increased numbers of GR1+ cells 
within the lungs of ASC-/- mice may indicate an inability by the host to effectively control 
Mtb during chronic infection. 
 
ASC-/- mice form fewer granulomas 
 To further explore the mechanism by which ASC enhances survival in chronically 
infected mice, we examined the histopathology of Mtb infected mouse lungs.  We 
70 
examined granuloma structure because of its role in containing bacteria during chronic 
Mtb infection (Ulrichs and Kaufmann, 2006) and because ASC-/- mice exhibit an abrupt 
drop in survival during the chronic phase of infection.  We assessed lung inflammation 
16 weeks post infection by measuring the amount of inflamed tissue from each mouse 
lung (see experimental procedures).  Low magnification images showed that the 
alveolar spaces of wild type, ASC-/-, Nlrp3-/-, and Casp-1-/- mice were obstructed by an 
influx of immune cells into the lung.  We found the lungs of all our gene depletion and 
wild type mice to be highly inflamed, ranging from 90-98 percent of the total lung tissue 
(Figure 2.13 A-B).  In all infected mice we observed dense areas of immune cells, 
indicative of granulomatous lesions.  Strikingly, the ASC-/- animals formed significantly 
fewer granulomas per lung compared to wild type, Nlrp3-/-, and Casp-1-/- lungs (Figure 
2.13 C-D).  Examination under higher magnification showed that wild type and Nlrp3-/- 
mice formed similar sized granulomas, hence ASC affected the formation of 
granulomas, but once they were formed, granuloma size was not affected by this gene 
(Figure 2.13 E-F).  Casp-1-/- mice formed larger granulomas, although this did not affect 
the outcome of infection.  To further assess the lung granuloma defect in ASC-/- mice we 
stained mouse lung sections with Ziehl Neelsen stain to identify Mtb.  Earlier data 
showed that the overall lung bacterial burden was similar in wild type and ASC-/-- mice 
by bacterial plating of homogenized lungs (Figure 2.5 A-B).  In contrast, analysis of 
acid fast staining revealed striking differences in bacterial localization in wild type and 
ASC-/- lungs.  Acid fast staining of wild type lungs shows very little Mtb located in non-
granulomatous lung tissue.  In contrast, ASC-/- mice contain bacteria throughout the 
lung and have extremely high amounts of bacteria in tissue that is not associated with 
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granulomas (Figure 2.14 A).  The amount of bacteria located outside of the granuloma 
was quantified by using a scale of 0-4 based on the amount of bacteria present in lung 
tissue that was not associated with granulomas (see experimental procedures) (Figure 
2.14 H).  ASC-/- mice form significantly fewer lung granulomas than wild type mice.  The 
acid-fast staining data demonstrate that ASC-/- animals were unable to contain bacteria 
within granulomas, shown by massive amounts of Mtb located in non-granulomatous 
lung tissue compared to wild type mice.  Reduced CD11c+ CD11bmid/low cells and 
granulomas in the lungs of ASC-/- provide plausible mechanisms to explain the 
decreased lifespan observed in these animals during chronic Mtb infection. 
 
DISCUSSION 
 In this report, we focus on the ability of virulent Mtb to stimulate inflammasome 
activation and the role of the inflammasome in host defense against Mtb.  Prior studies 
have implicated the inflammasome in mycobacterium infection in vitro.  Consistent with 
our data, one report showed that M. marinum, a mycobacterium that naturally infects 
fish and amphibians, activates IL-1β production in a ASC, NLRP3, and caspase-1-
dependent manner in vitro, but no in vivo investigation was conducted (Koo et al., 
2008).  Another report showed that M. bovis BCG, the vaccine strain of Mtb, can limit 
caspase-1 and IL-1β activation due to a putative protease Zmp1.  In this latter study, 
however, there was no analysis of ASC, Nlrp3 or Nlrc4 to directly implicate the 
inflammasome components (Master et al., 2008).  A third report showed that Mtb 
infected THP-1 human monocyte cell line secrete IL-1β in a ASC and NLRP3-
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dependent process, but did not investigate the role of the inflammasome in vivo (Mishra 
et al., 2010). 
 Our study showed that virulent Mtb H37Rv, along with the attenuated derivative 
Mtb H37Ra, induced NLRP3, ASC, and caspase-1-dependent inflammasome activation 
in a human macrophage cell line and in primary mouse macrophages.  However these 
in vitro results do not predict the outcome in mice.  Most importantly, this study showed 
that ASC is important for host protection during chronic infection with virulent Mtb 
infection in vivo, demonstrated by decreased survival of ASC-/- mice compared to wild 
type controls.  ASC did not confer a survival advantage through the production of IL-
1β.  Rather it functions to prolong host survival through a novel inflammasome 
independent role likely through appropriate presence of CD11c+ CD11bmid/low cells in the 
lung and granuloma formation during chronic Mtb infection.  Surprisingly, neither Nlrp3 
nor Casp-1 played a prominent role in host protection during Mtb infection in vivo 
despite its importance in culture.  The inconsistencies between the in vitro and in vivo 
role of Nlrp3 and Casp-1 underscores the absolute necessity for in vivo validation in 
relating host immune genes to the outcome of microbial infections. 
 IL-1β cleavage is a hallmark of inflammasome activation and we observed 
significant ASC, Nlrp3, and Casp-1-dependent inflammasome activation during in vitro 
infection of cultured cells.  However in our in vivo studies, we observed mature IL-1β in 
the lungs of Mtb infected wild type, ASC-/-, Nlrp3-/-, and Casp-1-/- mice.  This, along with 
mouse survival data, indicates that ASC host protection during Mtb infection in vivo is 
inflammasome independent.  The similar survival profiles of Nlrp3-/- and Casp-1-/- mice 
compared to wild type mice may be due to compensatory mechanisms of IL-1β 
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processing.  It is important to note that the inflammasome is not the only host 
mechanism for cleaving pro-IL-1β to its active form.  Through less well established, 
caspase-1-independent IL-1β cleavage can be carried out by several other host 
proteases including granzyme A, chymase, chymotrypsin, and matrix 
metalloproteinases as well as bacterial enzymes (Black et al., 1988; Irmler et al., 1995; 
Mizutani et al., 1991; Schonbeck et al., 1998).  Meanwhile ASC-/- mice lacked an 
additional mechanism to form or maintain granulomas, thus compromising their 
resistance to Mtb infection. 
 During chronic Mtb infection we found that lungs of ASC-/- mice had a 
dramatically reduced CD11c+ CD11bmid/low cell population compared to wild type lungs.  
CD11c+ cells are present in both human and mouse granulomas, and progressively 
increase in the lung during chronic Mtb infection (Tsai et al., 2006; Uehira et al., 2002).  
Despite a decrease in the CD11c+ CD11bmid/low cell population, T cells from ASC-/- mice 
are not inherently defective in T-cell function after stimulation with CD3/CD28 or Mtb-
specific PPD.   
 To investigate the mechanism further, we show that ASC-/- mice have fewer lung 
granulomas compared to wild type, Nlrp3-/-, or Casp-1-/- mice, despite having the same 
amount of inflamed lung tissue.  Acid-fast staining for Mtb localization within the lung 
demonstrated that ASC-/- mice are defective in containing Mtb with in granulomas, as 
shown by large amounts of bacteria found in non-granulomatous lung tissue.  In 
comparison, infected wild type mice have almost no bacteria found outside of 
granulomas.  Our data show that overall the lungs of ASC-/- and wild type mice have the 
same amount of bacteria, however the localization of Mtb within the lung is radically 
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different.  These data support a working hypothesis that ASC affects proper DC 
accumulation during chronic Mtb infection and promotes proper granuloma formation. 
 Recently, another group implicated an inflammasome-independent role for ASC 
in host protection against Mtb in vivo, but did not investigate the mechanism by which 
this was occurring (Mayer-Barber et al.).  In contrast to our data, this paper found that 
Casp-1 deficient mice had decreased survival during Mtb infection.  This may be due to 
differences in the amount of bacteria delivered to the mice or mouse housing conditions.  
Nonetheless, both their and our papers come to the same conclusion: that ASC has a 
role in host protection independent of Nlrp3.  
 In summary, this work demonstrates that ASC promotes survival during the late 
phase of Mtb infection independent of inflammasome activation.  This result also 
highlights the importance of ASC in the process of granuloma formation during chronic 
Mtb infection.  Considering the high rates of chronic Mtb infection worldwide and the 
increasing number of multi-drug resistant and extensively drug resistant tuberculosis 
cases, our study suggests that understanding the role of ASC during Mtb infection may 
lead to new and more effective therapies to treat chronic Mtb infection.  In contrast, the 
lack of a role for NLRP3 and caspase-1 in the in vivo containment of Mtb is encouraging 
for the development of inhibitors for autoinflammatory disorders.  These results suggest 
that anti-NLRP3 and caspase-1 strategies are not likely to cause the inadvertent 
activation of latent Mtb infection in patients. 
 
EXPERIMENTAL PROCEDURES 
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Generation of shRNA knockdown THP-1 cell lines.  shRNA knockdown and control 
vectors for ASC and NLRP3 have been described previously (Taxman et al., 2006).  All 
shRNA hairpins were confirmed by sequencing (Table 2.1).  Lentiviral packaging and 
transduction of THP1 cells has been previously described (Moore et al., 2008).  
Verification by RT-PCR indicated a significant reduction in ASC and NLRP3 expression 
(Figure 2.1 A-B).  Functionally, shASC and shNLRP3 had reduced IL-1β production in 
response to LPS (Figure 2.1 C). 
 
Bacterial strains.  Mtb H37Rv and H37Ra were obtained from the.  Bacteria were 
grown to log phase in Middlebrook 7H9 broth (Difco) with 0.2% glycerol, 1× albumin 
dextrose saline, and 0.05% Tween 80.  Inoculum was assessed by plating infection 
media on Middlebrook 7H10 agar plates supplemented with glycerol and ADS as 
described above.  Colony forming units (cfu) were counted after 21 days of incubation. 
 
Mtb infection of cultured cells.  Cell lines were cultured in RPMI (Gibco) with 10% 
FBS (Hyclone).  Bone marrow derived macrophages were harvested from 6- to 8-week-
old mouse femurs and cultured for 6 days in DMEM supplemented with L-glutamine, 
non-essential amino acids, 10% fetal bovine serum, and 20% L929 conditioned media.  
Thioglycolate elicited macrophages were obtained by peritoneal lavage 4 days after 
intraperitoneal injection with 3% thioglycolate and cultured in DMEM supplemented as 
above.  All cells were infected under BSL3 conditions with Mtb H37Rv or H37Ra at an 
MOI of 10 and incubated for 8 hours at 37°C with 5% CO2.  Cell free supernatants were 
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harvested, double filtered with 0.2µ filters, and assayed for cytokines by ELISA and 
western blot. 
 
Mtb H37Rv aerosol infection of mice.  Generation of ASC-/-, Nlrp3-/-, Casp-1-/-, and 
Nlrc4-/- mice (Kuida et al., 1995; Mariathasan et al., 2004; Sutterwala et al., 2006) have 
been described previously and were backcrossed onto C57BL/6 (Jackson Lab) 
background for a minimum of 9 generations.  Female ASC-/-, Casp-1-/- Nlrp3-/-,and Nlrc4-
/- mice and age matched C57BL/6 female controls were infected via aerosol as 
previously described (Kurtz et al., 2006).  Mice received 250-350 colony forming units 
per lung, determined by sacrificing a subset of mice 1d post infection as described by 
others (Kurtz et al., 2006).  Bacterial organ burden was quantified by plating serial 
dilutions of lung, liver, and spleen homogenates on 7H10 plates containing 
cycloheximide (1µg/ml) and carbenicillin (50µg/ml) to minimize contamination.  Animal 
infections and organ harvests were carried out under BSL3 conditions.  All studies were 
conducted in accordance with the National Institutes of Heath Guide for the Care and 
Use of Laboratory Animals and the Institutional Animal Care and Use Committee 
(IACUC) guidelines of the University of North Carolina at Chapel Hill. 
 
Cytokine determination.  Cytokines were measured from infected cell supernatants 
with human or mouse BD OptEIA IL-1β, TNFα, and IL-6 ELISA Sets (BD Biosciences) 
and IL-18 ELISA (MBL International).  In vivo cytokines were measured from lung 
homogenate extracts by centrifuging homogenized lung tissue to create a tissue free 
supernatant.  Amounts of pro- and cleaved IL-1β in lung homogenate extracts were 
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determined by Western blot.  Immunoblots were probed with goat anti-mouse IL-1β 
primary antibody (R&D Biosystems).  Bands were visualized by Super Signal 
Chemiluminescence (Pierce). 
 
Histopathology.  Lungs were fixed in 10% buffered formalin and stained with H&E to 
evaluate airway inflammation and identify granulomas.  The percent of inflamed lung 
tissue was determined by dividing the inflamed areas by the total lung area.  Granuloma 
frequency was determined by counting the number of granulomas present in the total 
lung section.  Granuloma size was measured by defining the granuloma borders for 26 
lesions using Image J software and determining the average.  Ziehl-Neelsen (ZN) 
staining was used to determine bacterial localization.  The entire Mtb infected mouse 
lung was scored on a scale from 0-4:  0=no bacteria found outside of granulomas, 1=1-
5 bacteria found outside of granulomas, 2=6-20 bacteria found outside of granulomas, 
3=approximately half of each field contains 20-50 bacteria outside of granulomas, and 
4= greater than half of each field contains greater than 50 bacteria outside of 
granulomas.  H&E lung sections were blindly scored by E.M., I.C.A., M.S., and P.H.  ZN 
stained lung sections were blindly scored by M.S. and P.H.  For all histology 
quantification 4-8 mouse lungs per genotype were analyzed. 
 
Whole lung digest and T-cell restimulation assays.  Lungs were digested in dispase 
at room temperature for 45 minutes.  Immune cells were removed and stained with 
CD11b (M1/70) and CD11c (N418) antibodies (eBioscience).  Splenocytes and MLN 
cells were harvested from the same mice and, along with lung cells, were incubated for 
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5 hours with Brafeldin A (7ug/ml) alone or in combination with CD3 (145-2C11)/CD28 
(37.51)(2.5ug/ml each) or PPD (1/40 dilution)(Synbiotics).  Lung, spleen, and MLN cells 
were stained with CD4 (L3T4), CD8 (Ly-2), and intracellular IFN-γ (XMG1.2) antibodies 
(eBiosciences).  Samples were analyzed by flow cytometry on FACSCalibur. 
 
Statistics.  Data are presented as the means +/- standard deviation (SD) unless 
otherwise noted.  Analysis Of Variance (ANOVA) followed by Tukey-Kramer HSD for 
multiple comparisons was performed on complex data sets.  Statistical significance for 
single data points was assessed by the Student’s two-tailed t-test.  Survival curves were 
generated utilizing the product limit method of Kaplan and Meier and comparisons were 
made using the log rank test.  In all cases, a p-value of less than 0.05 was considered 
statistically significant. 
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FIGURES 
 
 
 
 
Table 2.1.  Target sequences for shRNA THP-1 cell lines.  Target sequences for 
human ASC and NLRP3 shRNA hairpins used to construct stable knockdown THP-1 
cell lines. 
81 
 
 
 
 
 
 
 
 
Figure 2.1.  Validation of shRNA THP-1 cell lines.  A-B.  To ensure shRNA THP-1 
cell lines had reduced gene expression we measured human NLRP3  (A) and ASC (B) 
gene transcript by RT-PCR.  C.  Functional knockdown was shown by reduced IL-1β 
production in shASC and shNLRP3 THP-1 cell lines after LPS stimulation. 
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Figure 2.2.  Mycobacterium tuberculosis induced IL-1β in a human monocytic cell 
line required ASC and NLRP3.  A.  Virulent Mtb H37Rv induced IL-1β release was 
decreased in THP-1 cells stably transduced with ASC and NLRP3-specific shRNAs 
(shASC and shNLRP3, respectively) but not in cells transduced with an empty vector 
(EV) or scrambled shRNAs (mut) or untreated (NT) cells.  B.  Mtb induced IL-18 
secretion was observed in EV and mut controls but not with THP-1 cells transduced with 
shASC and shNLRP3.  C.  Attenuated Mtb H37Ra, similar to virulent Mtb H37Rv, 
induced ASC and NLRP3-dependent IL-1β release.  D.  Caspase-1 specific inhibitor 
(YVAD-CHO, 100 µM) blocked Mtb induced IL-1β. In THP-1 cells expressing an empty 
vector (EV).  For all experiments non-adherent THP-1 cells were infected with Mtb at 
MOI 10 for 8 hours.  IL-1β and IL-18 secretion were determined by ELISA.  Error bars 
represent SD of a representative experiment.  All experiments were repeated a 
minimum of three times.  ** p<0.001 
83 
 
 
 
 
Figure 2.3.  Mycobacterium tuberculosis induced ASC, Nlrp3, and Casp-1 
dependent IL-1β release in primary macrophages.  A. ASC-/-, Nlrp3-/-, and Casp-1-/- 
BMDM have decreased levels of IL-1β in response to Mtb H37Rv infection compared to 
WT or untreated (NT) BMDM.  B.  Attenuated Mtb H37Ra, similar to virulent Mtb 
H37Rv, induced ASC and Nlrp3-dependent IL-1β release.   C.  Thioglycolate elicited 
macrophages infected with Mtb H37Rv and Mtb H37Ra induced ASC and Nlrp3-
dependent IL-1β release.  Error bars represent SD of a representative experiment.  
Each experiment was repeated a minimum of three times. * p<0.05 
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Figure 2.4.  ASC-/- mice have significantly increased mortality following Mtb 
H37Rv aerosol infection.  Mice were infected by aerosol with each lung receiving 250-
350 cfu.  A. ASC-/- mice infected with Mtb H37Rv die significantly earlier than age and 
sex matched wild type mice (**p=0.0011; log rank).  Mean survival ASC-/- =137 vs. 
WT=214 days post infection.  B.  Repeat infection of ASC-/- mice and wild type mice 
confirmed survival phenotype with mean survival ASC-/- =148 vs. WT=203 days post 
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infection (p<0.0001; log rank).  C. No significant difference in survival was observed 
between Nlrp3-/- and WT mice after Mtb H37Rv infection.  Mean survival Nlrp3-/- =211 
vs. WT=214 days post infection.  D.  Repeat of Nlrp3-/- survival confirmed no difference 
between Nlrp3-/- and WT mice.  Mean survival Nlrp3-/- =206 vs. WT=214 days post 
infection.  E. Mtb infection of Nlrc4-/- mice showed no significant difference in survival 
compared to wild type mice.  Mean survival Nlrc4-/- =190 vs. WT=198 days post 
infection. 
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Figure 2.5.  Bacterial burden of ASC-/- mice is not increased following Mtb H37Rv 
aerosol infection.  A-F.  Bacterial organ burden. (A-B) Lungs, (C-D) liver, and (E-F) 
spleen of Mtb infected ASC-/-  (A,C,E) and Nlrp3-/- (B,D,F) mice.  Each gene-deletion 
mouse was individually controlled by concurrent infection of wild type mice.  Error bars 
represent SD of a representative experiment.  Organ burden data were obtained from 
two independent experiments each containing at least three mice per genotype. 
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Figure 2.6.  During Mtb infection ASC-/- and Nlrp3-/- mice produce similar levels of 
mature IL-1β when compared to wild type animals.  Lung homogenates were 
centrifuged and the extract collected to assess the levels of proinflammatory cytokines 
in the lung at each indicated time point.  A-B.  Cytokine measurements of IL-1β by 
ELISA (A) and western blot detection of pro- and cleaved IL-1β in lung homogenates 
one week (B, top panel) and 16 weeks (B, bottom panel) post aerosol infection.  IL-1β 
levels in ASC-/- and Nlrp3-/- mice were higher than wild type animals. Each number 
represents a different mouse.  C-D.  Cytokine measurements of IL-6 (C) and TNFα (D) 
increased during acute infection, but IL-6 and TNFα returned to base line level by week 
16.  IL-6 and TNFα were modestly increased in Nlrp3-/- mice when compared to ASC-/- 
and WT controls.  Cytokine measurements were taken from at least three mice per 
genotype in two independent experiments. *p <0.05 
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Figure 2.7.  Casp-1 is not protective during Mtb infection. 
A.  Casp-1-/- mice infected with Mtb did not have a difference in survival compared to 
wild type mice.  B-C.  Bacterial burden in the lungs, liver, and spleen was comparable 
between Casp-1-/- and wild type mice.   
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Figure 2.8.  During Mtb infection Casp-1-/- mice produce similar levels of mature 
IL-1β when compared to wild type animals.  A.  Casp-1-/- lungs contained significantly 
more mature IL-1β than wild type lungs by ELISA (* p<0.05).  B.  Western blot detection 
of pro- and cleaved IL-1β in lung homogenates one week (B, top panel) and 20 weeks 
(B, bottom panel) post aerosol infection indicate that both pro and cleaved IL-1β are 
increased during chronic infection in both wild type and Casp-1-/- lungs.  C-D.  Cytokine 
measurements of IL-6 (C) and TNFα (D) increased during acute infection and plateaued 
during the chronic phase of Mtb infection.  Cytokine measurements were taken from at 
least three mice per genotype in two independent experiments. 
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Figure 2.9.  ASC does not affect MAP kinase or NFκB signaling pathways during 
Mtb infection.  A-B.  BMDM from ASC-/- mice showed a modest decrease in activation 
of the NFκB signaling pathway compared to wild type following Mtb infection measured 
by phosphorylation of IκBα (A) and NFκB p65 (B).  C-D.  Slight differences were also 
found in activation of MAPK proteins shown by phosphorylation of signaling proteins 
ERK (C), and JNK, but not p38 (D). 
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Figure 2.10.  ASC-/- mice produce equal numbers of Mtb-antigen specific T-cells to 
wild-type mice during chronic Mtb infection.  A-F.  Lung cells (A-B), splencytes (C-
D) and MLN cells (E-F) from the same mice that were left unstimulated or restimulated 
with CD3/CD28 or PPD for 5 hours showed no difference in CD4 and CD8 T-cell 
function, demonstrated by IFN-γ production.  
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Figure 2.11.  ASC-/- mice have fewer CD11c+ CD11bmid/low cells during chronic Mtb 
infection.  A.  Lungs from ASC-/- and wild type mice had similar levels of total cells 90 
days post Mtb infection.  B-C.  Flow cytometry analysis showed that the lungs of ASC-/- 
mice have a reduced CD11c+ CD11bmid/low cell population compared to wild type (n=6 
per genotype, **p=0.000015)   
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Figure 2.12.  ASC-/- mice increased GR1+ lung cells during chronic Mtb infection.  
A.  Lungs from ASC-/- and wild type mice were harvested 90 days after Mtb infection 
and immune cell populations were identified by flow cytometry.  The lungs of ASC-/- 
mice have an increased GR1+ cell population compared to wild type (n=5 per genotype, 
** p=0.000383)   
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Figure 2.13.  ASC-/- mice have fewer lung granulomas during chronic Mtb 
infection.  Lungs were harvested 16 weeks postinfection, inflated, and fixed for 
histological sectioning.  A-B. Whole lung images of Mtb infected lungs show similar 
percentages of inflamed lung tissue for all Mtb infected mice.  C-D.  40X images 
demonstrate that ASC-/- mice form significantly fewer granulomas compared to wild 
type, Nlrp3-/-, and Casp-1-/- mice (* p<0.05).  E-F.  400X images demonstrate wild type, 
ASC-/-, and Nlrp3-/- mice form similarly sized granulomas while Casp-1-/- mice form 
significantly larger granulomas (**p<0.001).  Lung histopathology was analyzed from at 
least three mice per genotype in two independent experiments.  Quantification was 
performed on sections from 4-8 mouse lungs per genotype. 
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Figure 2.14.  ASC-/- mice are unable to contain bacteria within granulomas.  A-B.  
Acid-fast staining of Mtb infected lung sections illustrate dramatic differences in bacterial 
localization within ASC-/- lungs.  Different images of non-granulomatous regions of Mtb 
infected lung tissue taken at 100x and 400x demonstrate that wild type lungs contain 
very little Mtb in non-granulomatous tissue in contrast with ASC-/- mice which contain 
great numbers of Mtb throughout the lung (*p<0.01).  To view bacteria within a single 
macrophage 1000x images were selected, cropped, and enlarged.  Lung histopathology 
was analyzed from at least three mice per genotype in two independent experiments.  
Quantification was performed on sections from 4-8 mouse lungs per genotype.  
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ABSTRACT  
 The NLR gene family mediates host immunity to various acute pathogenic 
stimuli.  Here we investigated the role of NLRP12 during Mtb infection.  Previous 
data found that NLRP12 played an anti-inflammatory role during Mtb infection of 
a human monocytic cell line, occurring through inhibition of canonical and non-
canonical NFκB signaling.  We hypothesized that NLRP12 would be protective 
against Mtb infection, resulting in increased lung cytokines following Mtb 
infection.  In contrast to our hypothesis, Nlrp12 deficient mice did not have 
increased lung cytokines in response to Mtb infection.  We found no difference in 
survival of Nlrp12-/- mice compared to wild-type controls.  Bacterial burden of the 
lungs as well as Mtb dissemination to the liver and spleen was also similar 
between Nlrp12-/- and wild-type mice.  These data indicate that Nlrp12 does not 
play a prominent role in the host response to Mtb infection in vivo. 
 
INTRODUCTION 
 Mycobacterium tuberculosis (Mtb) is the causative agent of tuberculosis, a 
disease affecting one-third of the world’s population and resulting in 1.7 million 
deaths per year (2007).  Mtb is transmitted via aerosol from person to person.  
Upon inhalation, Mtb travels to the alveolar spaces of the lung where it infects its 
primary targeted cell type, the alveolar macrophage (Leemans et al., 2001).  The 
innate immune response to Mtb occurs through stimulation of TLRs that 
recognize pathogens and are located on the plasma membrane and within 
endosomes of host cells.  Mtb is specifically recognized by TLRs 2, 4, and 9 
104 
(Quesniaux et al., 2004).  TLR activation upregulates transcription of 
proinflammatory cytokines IL-1β, TNFα, and IL-6, which are essential for the 
recruitment of immune cells to the site of infection and controlling Mtb infection 
(Bean et al., 1999; Ladel et al., 1997; Yamada et al., 2000).  Pro-inflammatory 
cytokine regulation is critical to long-term survival during Mtb infection.  Mice 
deficient in pro-inflammatory cytokines TNFα and IL-6 have increased mortality 
during Mtb infection (Bean et al., 1999; Ladel et al., 1997).  TNFα is important for 
granuloma formation and maintenance (Flynn et al., 1995).  Therefore, these 
cytokines are not only important in the innate immune response to Mtb, but also 
in host defense during chronic Mtb infection. 
 NLRP12 (also Monarch-1) is a member of the nucleotide binding domain, 
leucine rich repeats-containing family proteins (NLR) which sense pathogens and 
pathogen products in the cell cytoplasm (Ting et al., 2008).  The NLR family 
proteins are increasingly associated with immune regulation, inflammation, and 
autoimmunity.  Mutations in NLRP12 have been linked to Familial Mediterranean 
Fever and recently a polymorphism in NLRP12 has been loosely associated with 
atopic dermatitis (Jeru et al., 2008; Macaluso et al., 2007).   
 Nlrp12 is highly expressed in human myeloid cells including monocytes, 
granulocytes, and eosinophils (Williams et al., 2003).  NLRP12 is able to bind 
ASC in an artificial overexpression system (McConnell and Vertino, 2004).  
Studies in the human monocytic cell line THP-1 identified NLRP12 is a negative 
regulator of TLR and TNF receptor signaling (Williams et al., 2005).  In addition, 
Mtb infection of THP-1 cells with reduced NLRP12 expression via shRNA 
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resulted in increased levels of pro-inflammatory cytokines.  This demonstrates 
that NLRP12 is an anti-inflammatory protein, downregulating cytokines through 
suppression of NFκB signaling (Lich et al., 2007; Williams et al., 2005).  In 
addition to NLRP12, NLRX1 and NLRC5 have recently been identified as anti-
inflammatory NLRs through inhibition of type I IFN and NFκB signaling pathways 
(Cui et al., 2010; Moore et al., 2008).  Consistent with the anti-inflammatory role 
of NLRP12 in cultured macrophages, we hypothesized that mice lacking Nlrp12 
will have increased lung cytokines after aerosol Mtb infection.  We also 
hypothesize that survival of Nlrp12 deficient mice may be reduced following Mtb 
infection, similar to the phenotype we observed in ASC-/- mice. 
 Tight regulation of Nlrp12 is important for initiation and termination of the 
host inflammatory response.  NLRP12 is highly expressed in human monocytes 
and macrophages, the primary target of Mtb.  In response to stimulation with 
TNF-α, IFN-γ, or Mtb NLRP12 expression is downregulated to allow the host to 
mount an inflammatory response (Williams et al., 2005).  B lymphocyte−induced 
maturation protein-1 (Blimp-1), a protein that regulates terminal differentiation of 
B cells and cells of the myeloid lineage, is partially responsible for the reduced 
expression of NLRP12 under inflammatory conditions (Chang et al., 2000; Lord 
et al., 2009).  This suggests a model in which during Mtb infection Blimp-1 
inhibits NLRP12 expression.  In the absence of NLRP12 the host is able to 
mount an immune response through increased NFκB signaling, resulting in an 
increase in pro-inflammatory cytokines.  To prevent an overzealous immune 
response, NLRP12 expression increases and inhibits NFκB signaling to 
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downregulate the host immune system.  This allows the host return to equilibrium 
following initiation of inflammatory signaling. 
 In this work, we examined the role of Nlrp12 in Mtb infection.  We find that 
Nlrp12 deficient mice have similar levels of pro-inflammatory cytokines during 
early and chronic Mtb infection.  Nlrp12 does not play a prominent role in host 
protection against Mtb, shown by survival and bacterial organ burden similar to 
wild-type mice. 
  
MATERIALS AND METHODS 
Bacterial strains.  Mycobacterium tuberculosis H37Rv and H37Ra were 
obtained from the American Type Culture Collection (ATCC).  Bacteria were 
grown to log phase in Middlebrook 7H9 broth (Difco) with 0.2% glycerol, 1× 
albumin dextrose saline, and 0.05% Tween 80.  Inoculum was assessed by 
plating infection media on Middlebrook 7H10 agar plates supplemented with 
glycerol and ADS as described above.  Colony forming units (cfu) were counted 
after 21 days of incubation. 
  
Mice.  Nlrp12-/- mice kindly supplied by Millenium Inc.  Mice were obtained 
backcrossed for 5 generations and were further backcrossed by the Ting Lab 
onto the C57BL/6 (Jackson Lab) background until reaching 9 generations.  All 
studies were conducted in accordance with the National Institutes of Heath Guide 
for the Care and Use of Laboratory Animals and the Institutional Animal Care and 
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Use Committee (IACUC) guidelines of the University of North Carolina at Chapel 
Hill. 
 
Mtb H37Rv aerosol infection of mice.  Female Nlrp12-/- mice and age matched 
C57BL/6 female controls were infected via aerosol as previously described (Kurtz 
et al., 2006).  Mice received 250-350 colony forming units per lung, determined 
by sacrificing a subset of mice 1d post infection as described by others (Kurtz et 
al., 2006).  Bacterial organ burden was quantified by plating serial dilutions of 
lung, liver, and spleen homogenates on 7H10 plates containing cycloheximide 
(1µg/ml) and carbenicillin (50µg/ml) to minimize contamination.  All animal 
infections and organ harvests were carried out under BSL3 conditions. 
 
Cytokine determination.  To measure cytokines in vivo we assayed lung 
homogenate extracts by centrifuging homogenized lung tissue to create a tissue 
free supernatant.  Cytokines were measured by BD OptEIA Mouse IL-1β, TNFα, 
and IL-6 ELISA Sets (BD Biosciences) 
 
Immunoblotting.  Amounts of pro- and cleaved IL-1β in lung homogenate 
extracts were determined by Western blot.  Immunoblots were probed with goat 
anti-mouse IL-1β primary antibody (R&D Biosystems).  
 
Statistics.  Data are presented as the means +/- standard deviation (SD) unless 
otherwise noted.  Analysis Of Variance (ANOVA) followed by Tukey-Kramer HSD 
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for multiple comparisons was performed on complex data sets.  Statistical 
significance for single data points was assessed by the Student’s two-tailed t-
test.  Survival curves were generated utilizing the product limit method of Kaplan 
and Meier and comparisons were made using the log rank test.  In all cases, a p-
value of less than 0.05 was considered statistically significant. 
 
RESULTS AND DISCUSSION 
 NLRP12 is known to be an anti-inflammatory NLR during Mtb infection 
cultured macrophages (Williams et al., 2005).  We envisioned three models in 
which Nlrp12 could play a role during Mtb infection in vivo.  In the first model, we 
hypothesized that the absence of Nlrp12 would cause an overzealous immune 
response leading to the destruction of lung tissue and increased inflammation.  In 
this environment aberrant cytokine secretion may cause disregulation of immune 
cell migration into and within the lung, preventing Nlrp12-/- mice from forming 
proper granulomas, and subsequently containing Mtb within granulomas.  This 
would result in increased bacterial organ burden and reduced survival of Nlrp12-/- 
mice compared to wild-type mice following Mtb infection.  In a second possible 
model, Nlrp12 interacts with ASC and together these proteins protect the host 
during Mtb infection.  In this scenario Nlrp12-/- mice would have the same 
phenotype that was observed in ASC-/- mice including reduced survival and fewer 
granulomas during chronic infection.  In contrast to these models, a third model 
was envisioned in which lack of Nlrp12 leads to increased cytokines.  Instead of 
causing destruction of host tissue, increased cytokines increased bacterial killing 
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and resulted in limited bacterial growth and reduced bacterial spread.  In this 
scenario we predict that Nlrp12-/- mice would have increased survival, living 
longer than their wild-type controls. 
 
Nlrp12-/- and wild-type mice have similar pro-inflammatory lung cytokines 
following Mtb infection.  
 To test these possible models, Nlrp12-/- and wild-type mice were infected 
with Mtb via aerosol.  Time points were taken at 1, 14, 26, and 177 days 
postinfection to evaluate bacterial burden and cytokines during both acute and 
chronic Mtb infection.  Pro-inflammatory lung cytokines IL-1β, TNFα, and IL-6 
were measured from cleared lung homogenates of Nlrp12-/- and wild-type mice.  
Surprisingly, proinflammatory cytokines were not increased during Mtb infection 
(Figure 3.1 A-C).  The amount of lung IL-1β increased in Nlrp12-/- mice as Mtb 
infection progressed.  TNFα and IL-6 levels were comparable between the lungs 
of Nlrp12-/- mice compared to wild-type controls at one day and postinfection as 
well as during chronic infection.  At day 14, surprisingly, we found that Nlrp12-/- 
lungs had reduced TNFα and IL-6 compared to wild-type that neared significance 
(p=0.056 and p=0.06, respectively).  This suggests in contrast to the anti-
inflammatory role NLRP12 played in human monocytes, in an in vivo model of 
Mtb infection Nlrp12 plays an inflammatory role.  Similar to our data from Nlrp3 
and Casp-1 deficient mice, infection of macrophages in culture was not predictive 
of the role of Nlrp12 in a mouse model of Mtb infection. 
 
110 
Nlrp12 does not protect the host during Mtb infection in vivo 
 Nlrp12-/- mice and wild-type control mice were infected with Mtb via 
aerosol infection.  Mouse survival was monitored postinfection and Nlrp12-/- mice 
were found to live as long as wild-type mice, but not longer (Figure 4.2 A).  This 
result indicates that Nlrp12 does not play a prominent role in host protection 
during Mtb infection. 
 
Bacterial lung burden and bacterial dissemination are unaffected by Nlrp12
 To determine if Nlrp12 has an effect on bacterial growth during in vivo 
infection we measured bacterial burden within the lungs at various time points 
post Mtb infection.  Lungs of Nlrp12-/- and wild type mice were harvested from 
mice during acute and chronic time points following Mtb infection.  In contrast to 
both proposed models, we saw no difference in the amount of Mtb within the 
lungs of Nlrp12-/- or wild type mice at any time point postinfection (Figure 4.2 B).  
In combination with data indicating that the amount of pro-inflammatory cytokines 
in the lung were unchanged in the absence of Nlrp12, we conclude that Nlrp12 
does not play a significant role in attenuating Mtb during infection, nor does it 
create an environment where Mtb can more easily replicate and spread.  
 We also measured the ability of bacteria to disseminate to secondary sites 
of infection within mice.  Bacterial dissemination to the liver and spleen occurs by 
14 days postinfection.  There were no differences between the bacterial burden 
of the liver and spleen when we compared Nlrp12-/- and wild type animals 
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(Figure 3.2 C-D).  These results indicate that Nlrp12 does not play a role in Mtb 
dissemination or growth at these secondary sites of infection. 
 Previous results indicated that ASC played a role in host protection during 
Mtb infection independent of the inflammasome.  NLRP12 is a non-
inflammasome forming NLR that suppresses cytokine production through 
inhibition of NFκB signaling (Williams et al., 2005).  Two additional NLRs, NLRC5 
and NLRX1, are anti-inflammatory in response to viral pathogens resulting in 
suppression of NFκB and type I IFN signaling.  NLRP12 is able to bind ASC in an 
artificial overexpression system (McConnell and Vertino, 2004).  We 
hypothesized that NLRP12 may play a role in host protection through association 
with ASC.  In addition we proposed two additional scenarios in which Nlrp12 
could play a role following Mtb infection in vivo.  Nlrp12 did not affect lung 
cytokine production, mouse survival, or bacterial burden in an in vivo model of 
Mtb infection.  This result demonstrates the importance of validating findings from 
cell culture in mouse models.  We also did not find a role for NLRP12 during 
infection with other bacteria such as Escherichia coli and Klebsiella pneumoniae 
(unpublished observation). However, in inflammatory models such as colitis, 
NLRP12 is found to attenuate inflammation in the gut (Allen IC et al., in 
preparation).  Furthermore, Nlrp12-/- macrophages also show a reduction in non-
canonical NF-kB activation (Lich et al., 2007). Thus NLRP12 does appear to 
attenuate inflammation, but does not appear to play a detectable role during Mtb 
infection. 
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FIGURES 
 
 
 
Figure 3.1.  During Mtb infection Nlrp12-/- mice produce similar levels 
cytokines compared to wild type animals.  A.  Nlrp12-/- lungs similar amounts 
of IL-1β compared to wild-type lungs at both early and chronic phases of Mtb 
infection.  B-C.  Cytokine measurements of TNFα (B) and IL-6 (C) showed that 
Nlrp12-/- and wild-type lungs had similar amounts of cytokines at one day 
postinfection and during chronic Mtb infection.  At 14 days postinfection, Nlrp12-/- 
lungs had reduced cytokines compared to wild-type lungsthat neared significance 
(p= 0.056 and p=0.06, respectively).  Cytokine measurements were taken from at 
least three mice per genotype. 
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Figure 3.2.  Nlrp12 is not protective during Mtb infection 
A.  Nlrp12-/- mice infected with Mtb did not have a difference in survival compared 
to wild type mice.  B-D.  Bacterial burden in the lungs, liver, and spleen was 
comparable between Nlrp12-/- and wild type mice.   
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CHAPTER 4 
DISCUSSION 
 
 Mtb infects one-third of the world’s population resulting in 9 million newly 
infected people and 2 million deaths per year (CDC, 2009).  The current BCG 
vaccine is not effective against adult pulmonary TB.  Resistant strains of Mtb are 
on the rise, and no new antibiotics have been developed since the 1960s.  A 
greater understanding of the interaction between Mtb and the host may lead to 
new and more effective vaccines and therapies to treat Mtb infection. 
 The overall goal of this thesis was to identify host proteins important for 
protection during Mtb infection.  We chose to study the NLR family, a group of 
proteins that function in immune regulation, inflammation, and autoimmunity 
(Ting and Davis, 2005).  We specifically chose to study the protein NLRP3, which 
detects a broad range of pathogens and pathogen products (Table 1.2).  Upon 
stimulation, NLRP3 forms an inflammasome with the adaptor protein ASC and 
pro-caspase-1 which results in caspase-1 processing and recruitment and 
cleavage of cytokines pro-IL-1β and pro-IL-18 to their active forms.  In chapter 2, 
we discovered that in cultured macrophages Mtb stimulates the NLRP3 
inflammasome in an ASC and caspase-1-dependent manner.  To determine if 
the NLRP3 inflammasome was important for host protection in vivo, we infected 
118 
mice lacking individual NLRP3 inflammasome genes Nlrp3, ASC, and Casp-1 
with Mtb via aerosol.  Mice lacking IL-1α/β, IL-1R, and IL-18 play a role in limiting 
bacterial lung burden, regulating other cytokines, nitric oxide production, and 
forming organized granulomas (Juffermans et al., 2000; Sugawara et al., 2001; 
Sugawara et al., 1999).  We hypothesized that mice lacking any of the Nlrp3 
inflammasome components would have reduced survival following an in vivo Mtb 
infection, primarily due to lack of cleaved IL-1β in these mice.  In contrast to our 
hypothesis, we found that only ASC played a role in host protection.  More 
specifically, we discovered ASC to be important during the chronic phase of Mtb 
infection.  The absence of either Nlrp3 or Casp-1 had no effect on mouse 
survival.  Another surprise in these studies was that mice lacking the Nlrp3 
inflammasome genes did not have reduced cleaved IL-1β in their lungs.  These 
data indicate that ASC protects the host in an inflammasome-independent 
manner during Mtb infection.  To further understand the host response to Mtb we 
investigated the role of ASC during chronic infection.  ASC-/- mice have a 
significantly reduced CD11c+ CD11bmid/low cell population that is present in the 
lungs of wild-type mice.  In addition, ASC-/- mice have fewer lung granulomas 
during the chronic phase of infection.  In ASC-/- mice, Mtb is spread throughout 
the lung instead of being contained within granulomas as is the case in wild-type 
mice.  The inability of ASC-/- mice to contain bacteria within granulomas 
constitutes a breakdown in host defense in response to Mtb infection.  Chapter 3 
focuses on the role of another NLR, Nlrp12, during an in vivo model of Mtb 
infection.  NLRP12 is an anti-inflammatory and non-inflammasome forming NLR 
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that is shown to bind ASC in vitro (Lich et al., 2007; Williams et al., 2005).  We 
hypothesized that Nlrp12-/- mice may have reduced survival similar to ASC-/- if 
Nlrp12 and ASC are interacting during Mtb infection.  Following Mtb infection 
Nlrp12-/- mice did not have reduced survival compared to wild-type mice.  This 
indicates that Nlrp12 does not play a prominent role in the host response against 
Mtb in an in vivo mouse model of disease.  Taken together, our data supports a 
novel, inflammasome-independent role for ASC in host protection against Mtb 
infection since neither Nlrp3 nor Casp-1 had reduced survival or defective 
granuloma formation after Mtb infection.  In addition, cleaved IL-1β was present 
in the lungs of all mice lacking Nlrp3 inflammasome components, including ASC-/- 
mice.  In this discussion, I will be addressing the future direction of the project 
and speculation as to the role of ASC in host protection following Mtb infection. 
 
Mtb stimulates the NLRP3 inflammasome in cultured macrophages 
 While our research was underway, three papers were published that 
report similar findings of Nlrp3 inflammasome activation occurring during Mtb 
infection in vitro.  The authors of the first study found that BMDM infection with M. 
marinum, a mycobacterium species that naturally infects fish and amphibians, 
resulted in IL-1β and IL-18 secretion (Koo et al., 2008).   Secretion of IL-1β and 
IL-18 was dependent on the NLRP3-inflammasome components Nlrp3 and ASC, 
but independent of the closely related inflammasome-forming NLR Nlrc4.  In the 
second report, the authors infected a murine macrophage cell line with M. bovis 
BCG, the attenuated vaccine strain of Mtb (Master et al., 2008).  Infection 
120 
resulted in Caspase-1 and IL-1β cleavage which is indicative of inflammasome 
activation.  However, in this paper the authors only measured caspase-1 
cleavage and did not investigate the role of any inflammasome components 
directly (Master et al., 2008).  The authors further reported that a mutation in a 
putative protease, Zmp-1, resulted in increased Caspase-1 activation compared 
to the wild-type strain of M. bovis BCG.  Master et al. (2008) conclude that 
mycobacteria contain proteins that modulate host defense mechanisms including 
some that limit caspase-1 activation.  Finally, a paper from Mishra et al. (2010) 
showed that Mtb-infected THP-1 cells secrete IL-1β in an Nlrp3 and ASC-
dependent manner.  The conclusions of all three of these studies correlate with 
our findings that Mtb activates the NLRP3 inflammasome in cultured 
macrophages and monocytes.  In agreement with our hypothesis, IL-1β secretion 
from these cells following Mtb infection is dependent on NLRP3, ASC, Caspase-
1, but independent of NLRC4.   
 
The role of the NLRP3 inflammasome in an in vivo mouse model of Mtb 
infection 
 Many pathogens stimulate the NLRP3 inflammasome in cell culture, but 
very few studies have investigated the role of NLR proteins in vivo.  To determine 
the role of the NLRP3 inflammasome during in vivo infection, we exposed mice 
lacking Nlrp3, ASC, and Casp-1 along with wild-type controls to Mtb via an 
aerosol route of infection.  During our cultured cell experiments, inflammasome 
activation was measured by secretion of IL-1β into the culture medium by ELISA 
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assay.  In vivo, cytokines were measured by ELISA assay from tissue-free lung 
homogenates.  The homogenization process causes loss of cellular integrity; 
therefore, we additionally measured IL-1β by western blot to distinguish between 
inactive pro-IL-1β and cleaved IL-1β within the mouse lung. 
 Data from cultured macrophages demonstrated that Mtb stimulates the 
NLRP3 inflammasome and cleavage of IL-1β was dependent on inflammasome 
proteins NLRP3, ASC, and caspase-1.  We hypothesized that IL-1β would not be 
cleaved in mice lacking Nlrp3 inflammasome components during an in vivo 
mouse model of Mtb infection.  Contrary to our hypothesis, we found that cleaved 
IL-1β was present in the lungs of both Nlrp3- and ASC-deficient mice after Mtb 
infection.  Initially after this surprising result, we theorized that other NLRs were 
being activated by Mtb in vivo and were forming an inflammasome with Caspase-
1 resulting the observed in IL-1β cleavage.  To investigate the source of cleaved 
IL-1β in the lungs of Nlrp3 and ASC mice we investigated the role of Caspase-1 
during in vivo Mtb infection. 
 The initial characterization of Casp-1-/- mice found that they were resistant 
to endotoxic shock and were unable to process pro-IL-1β and pro-IL-18 to their 
active forms after in vivo LPS exposure (Li et al., 1995).  Our in vitro studies 
determined that Casp-1 was essential for IL-1β cleavage in BMDM infected with 
Mtb.  Surprisingly, since Casp-1 is directly responsible for cleaving pro-IL-1β, we 
did not observe the same result in Mtb infected Casp-1-/- mice.  We detected 
wild-type levels of cleaved IL-1β in the lungs of Casp-1-/- mice following Mtb 
infection.  This unexpected result may be explained by additional lung proteases 
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that are able to cleave pro-IL-1β in the absence of Caspase-1.  The most 
thoroughly studied of these proteases are chymases which are released from 
mast cells upon degranulation (Mizutani et al., 1991).  Another protease that may 
play a role in cleaving pro-IL-1β include granzyme A, which is a serine protease 
produced by CD8+ T cells and NK cells that is released by cytoplasmic granules 
(Irmler et al., 1995).  Additionally, the matrix metalloproteinases (MMPs) are a 
family of membrane-associated and secreted endopeptidases, and MMP-2, -3, 
and -9 have been shown to process pro-IL-1β to its active form with varying 
kinetic efficiencies (Schonbeck et al., 1998).  Finally, the proteolytic enzyme 
chymotrypsin also processes pro-IL-1β into its active form (Black et al., 1988).   
 To explain why Casp-1-/- mice have cleaved IL-1β in their lungs during 
chronic Mtb infection, we propose a model in which dying cells release pro-IL-1β 
protein into the extracellular environment where the protein is cleaved to its 
active form by extracellular proteases in the absence of Caspase-1.  We 
speculate that caspase-1 is a more efficient protease than other extracellular 
proteases and is therefore preferred by the host for cleavage of pro-IL-1β.  In the 
absence of Caspase-1, the activity of other extracellular proteases may provide a 
compensatory mechanism for pro-IL-1β cleavage, resulting in cleaved IL-1β in 
the lungs of Casp-1-/- mice.  It is possible that this compensation is inefficient and 
requires additional time to obtain sufficient levels of cleaved IL-1β.  The duration 
of chronic Mtb infection may allow sufficient time for compensatory mechanisms 
of pro-IL-1β cleavage to be activated in the absence of Caspase-1.  Our results 
show that caspase-1-independent mechanisms of IL-1β cleavage are sufficient to 
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produce levels of IL-1β in mice lacking caspase-1 similar to that found in wild-
type during in vivo Mtb infection unlike in a cell autonomous culture system.  
 Nlrp3-, ASC-, and Casp-1-deficient BMDM did not secrete IL-1β during 
Mtb infection, but during in vivo Mtb infection, these mice produced as much 
cleaved IL-1β in their lungs as wild-type mice.  However, it is important to note 
that these in vivo results do not rule out the possibility that cleaved IL-1β is 
specifically reduced within the granulomas of the Nlrp3, ASC, and Casp-1 
deficient mice.  Differences in IL-1β within granulomas may be masked in the 
context of a whole lung homogenate.  In the future, immunohistochemistry could 
be used to identify the location of cleaved IL-1β in paraffin-embedded lung tissue 
of Nlrp3-/-, ASC-/-, and Casp-1-/- mice during chronic Mtb infection.  We 
hypothesize that the amount of cleaved IL-1β may be at least partially reduced 
within the granulomas of Nlrp3-/-, ASC-/-, and Casp-1-/- mice compared to wild-
type mice.  This is due to the fact that granulomas contain many macrophages 
which we have shown in cell culture models do not secrete IL-1β in the absence 
of Nlrp3 inflammasome components following Mtb infection.  Despite possible 
differences in the amount of IL-1β secreted within granulomas, these differences 
are unlikely to have a dramatic effect during Mtb pathogenesis.  This is indicated 
by the fact that mice lacking Nlrp3 and Casp-1 form the same number of 
granulomas as wild-type mice, suggesting that a reduction in IL-1β levels within 
granulomas was not responsible for the formation of fewer granulomas in the 
lungs of ASC-/- mice.  Reduced quantities of IL-1β in granulomas may lead to 
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differences in the lung immune cell composition of Nlrp3-/-and Casp-1-/-mice 
compared to wild-type mice, which we did not measure.  
 While our research was underway, an independent study was published 
and it confirmed our results that ASC-/- mice have reduced survival following Mtb 
infection (Mayer-Barber et al., 2010).  While we concluded that Caspase-1 did 
not play a role in host protection during Mtb infection, in the study of Mayer-
Barber et al. (2010), they report that Casp-1-/- mice have reduced survival 
compared to wild-type controls.  The difference results with Casp-1-/- mice may 
be explained by the housing conditions of Casp-1-/- mice following Mtb infection.  
We infected Casp-1-/- mice with Mtb in two independent experiments.  During the 
first experiment, we obtained results similar to Mayer-Barber et al. (2010), in 
which Casp-1-/- mice had reduced survival compared to wild-type mice.  The 
survival curve was biphasic with half the Casp-1-/- mice succumbing to infection 
approximately 40 days postinfection and the remaining mice persisting until 130 
days postinfection.  For comparison, wild-type mice in this experiment survived 
for approximately 200 days postinfection.  After completion of this experiment, we 
discovered that the Casp-1-/- mice were being housed in non-specific pathogen 
free (SPF) conditions.  The infection was repeated with Casp-1-/- mice housed 
under SPF conditions.  We found that the Casp-1-/- mice lived as long as wild-
type mice under SPF conditions, indicating that Casp-1 is not required for host 
defense during Mtb infection.  Our data suggests that the reduced survival of 
Casp-1-/- mice compared to wild-type mice seen in Mayer-Baber et al. (2010) and 
our first experiment may have been due to Mtb infection in combination with 
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other pathogens.  Caspase-1 has over 70 substrates, and it is possible that one 
or more could be playing a role in host resistance to pathogens making Casp-1-/- 
mice more susceptible to a range of animal pathogens (Keller et al., 2008; Shao 
et al., 2007).  Due to concern over housing conditions, we repeated the Mtb 
aerosol infection of ASC-/- mice and housed them under SPF conditions.  
Importantly, we observed the same survival phenotype of the ASC-/- mice under 
SPF and non-SPF conditions, allowing us to be confident that reduced survival of 
the ASC-/- mice was due solely to Mtb infection. 
 
Bacterial localization in the lungs of ASC-/- mice  
 As determined by plating for viable bacteria, our initial studies showed no 
difference in the bacterial burden of the lungs, liver, or spleen of ASC-/- mice 
compared to wild-type mice.  This result was somewhat unexpected as it is 
common for reduced survival to correlate with increased Mtb replication.  
Histopathological analysis of lung sections showed that ASC-/- mice contain fewer 
lung granulomas during chronic Mtb infection than to wild-type mice.  Through 
acid-fast staining, we observed that Mtb was spread throughout the lungs of 
ASC-/- mice.  This contrasts with wild-type mice in which Mtb is almost entirely 
contained within granulomas.  These data demonstrate that although the total 
bacterial burden is similar in the lungs of ASC-/- and wild-type mice, ASC-/- mice 
have a difference in bacterial localization within the lung. 
 
Granuloma formation vs. granuloma maintenance   
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 ASC-/- mice also have fewer granulomas than wild-type mice during 
chronic Mtb infection.  It is unknown if the reduced number of granulomas is due 
to a defect in granuloma formation or granuloma maintenance.  To address this 
question, we obtained lung tissue from ASC-/- and wild-type mice infected with 
Mtb for 21 days and analyzed it for signs of granuloma formation.  Perivascular 
accumulation of immune cells, a precursor to granuloma formation, was present 
21 days postinfection, but granulomas had not yet formed.  Histopathology of 
lungs 50 days after Mtb infection showed that ASC-/- and wild-type lungs had a 
similar number of granulomas.  However, these data cannot distinguish between 
the possibility of a defect in granuloma formation or maintenance.  If ASC-/- mice 
have stopped forming granulomas at 50 days postinfection while wild-type mice 
continue to form additional granulomas, we would conclude that ASC-/- mice have 
a defect in formation.  Alternatively, wild-type mice could have formed all their 
granulomas by 50 days postinfection and from this point on the number of 
granulomas in the ASC-/- mice will decline, indicating a defect in granuloma 
maintenance.  To further investigate this question, we would need to perform a 
more thorough study of the kinetics mouse granuloma formation.  This 
information may lead to an increased understanding of the role of ASC during 
granuloma formation. 
 
Differences in the lungs of ASC-/- and wild-type mice during chronic Mtb 
infection 
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 ASC-/- mice have reduced survival following Mtb infection compared to 
wild-type mice.  Although the mechanism by which ASC protects the host is not 
yet clear, we amassed several clues during the course of our research.  Using 
whole lung digests, we identified immune cell populations within the lung during 
chronic Mtb infection.  We found that ASC-/- lungs have a greatly reduced 
CD11c+, CD11bmid/low cell population compared to wild-type mice.  Different 
papers report that CD11c+, CD11bmid/low cells are DCs, alveolar macrophages, or 
a hybrid of the two cell types (Gonzalez-Juarrero et al., 2003; Hall et al., 2008; 
Matthews et al., 2007).   
 DCs are the main antigen-presenting cell of the body, bridging the innate 
and adaptive immune system.  During acute infection, DCs are highly migratory, 
a trait Mtb exploits by infecting DCs and using them for dissemination to other 
areas of the body.  DCs play an important role in antigen presentation to naïve T 
cells.  We have shown that despite the absence of lung CD11c+ CD11bmid/low 
cells, ASC-/- mice have similar numbers of Mtb antigen-specific T-cells in their 
lungs, mediastinal lymph nodes, and spleens compared to wild-type mice.  DCs 
are present in both mouse and human granulomas during chronic Mtb infection, 
but their role within the granuloma is unknown (Tsai et al., 2006; Uehira et al., 
2002).  We theorize that CD11c+ CD11bmid/low cells may play a structural role 
within the granuloma.  In the absence of this population we hypothesize that 
granuloma integrity is compromised, a phenotype seen in ASC-/- mice.  Because 
ASC-/- mice had similar numbers of antigen-specific T cells compared to wild-type 
mice, we speculate that CD11c+ CD11bmid/low cells do not play a prominent role in 
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activation of naïve T cells, or their role is compensated by other antigen-
presenting cells.  
 CD11c+ CD11bmid/low cells may also represent an intermediate cell type 
between dendritic cells and macrophages (Matthews et al., 2007).  These hybrid 
cells retain some characteristics of each cell type.  This was demonstrated in a 
report in which CD11c+ CD11b- cells were able to phagocytose OVA, but were 
unable to process and present OVA antigen.  We envision a model in which 
these hybrid cells are recruited to the granuloma where they are infected by Mtb 
or take up Mtb proteins.  Within the granuloma, the hybrid cells are unable to 
process and present antigen (Matthews et al., 2007).  In addition, they do not 
upregulate activation markers required for migration out of the lung.  Similar to 
our hypothesis for DCs, we suggest that these cells may provide structure within 
the granuloma, and in their absence granuloma integrity may be compromised, 
indicative of the phenotype present in ASC-/- mice. 
 Alveolar macrophages are another cell population classified as CD11c+, 
CD11bmid/low.  Similar to DCs, they are present within lung granulomas.  A recent 
study observed that the number of pulmonary macrophages increased during 
Mtb infection as detected by histology, but the number of macrophages 
recovered in BAL fluid does not increase during infection (Redente et al., 2010)  
This indicates that large numbers of macrophages are recruited to the lungs but 
these cells are not migrating out of the lungs.  Redente et al. (2010) speculate 
that retention of macrophages within the lung may be due to their tight adherence 
properties.  Complete depletion of alveolar macrophages during Mtb infection 
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results in defective granuloma formation (Leemans et al., 2001).  Due to alveolar 
macrophages being the primary cell type infected by Mtb during initial infection, 
their role in chronic infection alone is difficult to surmise from this model.  These 
examples allow us to hypothesize that alveolar macrophages within Mtb-induced 
granulomas comprise the infected core as well as surrounding uninfected 
macrophages.  Within granulomas, alveolar macrophages may be important for 
providing structure due to the adherent properties of macrophages.   
  Whether the CD11c+ CD11bmid/low cell population consists of DCs, 
alveolar macrophages, or both cell types, we are interested in determining their 
function during chronic Mtb infection.  We hypothesize that CD11c+, CD11bmid/low 
cells may play a role in granuloma structure, either directly by providing 
scaffolding similar to Langerhans cells, or indirectly by regulating chemokine 
gradients and co-stimulatory molecules which recruit and direct immune cells 
within the Mtb-infected lung.  In the absence of CD11c+, CD11bmid/low cells, ASC-/- 
mice have fewer granulomas than wild-type mice and are unable to contain Mtb 
within granulomas.  To further study this cell population, we could repeat whole 
lung digests of ASC-/- and wild-type mice during chronic Mtb infection and 
perform flow cytometry analysis using additional antibodies to further classify 
CD11c+, CD11bmid/low cells.  F4/80 antibody could be used to differentiate 
between alveolar macrophages (F4/80+) and DCs (F4/80-).  In addition, we would 
stain cells with antibodies for activation markers (CD40, CD86,80, MHC class II) 
on macrophages and DCs.  Determining the activation state of macrophages and 
DCs would provide hints to their functional role during chronic Mtb infection.  In 
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addition we could perform immunohistochemistry on paraffin-embedded lung 
tissue sections to identify localization of CD11c+ CD11bmid/low within ASC-/- and 
wild-type lungs.  Cytokine and chemokine staining that colocalizes with areas of 
CD11c+ cells may provide hints as to what these cells are doing within specific 
areas of the lung, something not possible to detect by flow cytometry.   
Additionally, we could identify chemokines that CD11c+ CD11bmid/low cells migrate 
towards, and then see if these chemokines are reduced in ASC-/- mice during Mtb 
infection.  We could confirm the importance of the chemokine by either 
challenging a gene depletion mouse for the specific chemokine with Mtb or by 
neutralizing the chemokine in a wild-type mouse during chronic Mtb infection.  In 
both cases we hypothesize that the mice would have reduced granulomas similar 
to the phenotype we observed in ASC-/- mice. 
 In addition to differences in the CD11c+, CD11bmid/low cell population, our 
whole lung digests identified an increase in GR1+ cells within the lungs of ASC-/- 
mice.  Neutrophils are usually present during the first two weeks of infection after 
which their numbers drop within the lungs (Gonzalez-Juarrero et al., 2001).  We 
hypothesize that the increase GR1+ cells is a result of Mtb located throughout the 
lungs of ASC-/- mice rather than contained within granulomas as in wild-type 
mice.  We hypothesize that ASC-/- mice may constantly recruit GR1+ cells to the 
lung to combat Mtb, thereby creating a lung environment that constantly mimics 
initial Mtb infection.  It is possible that increased lung GR1+ cells are destructive 
to the lung tissue, directly resulting in reduced survival of ASC-/- mice following 
Mtb infection.  To test this hypothesis, we could use neutralizing antibodies 
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against GR1+ during chronic Mtb infection to determine if ASC-/- mice live as long 
as wild-type controls. 
 
Functions of ASC independent of the inflammasome 
 A key finding in our studies is that ASC plays an inflammasome-
independent role in host defense against Mtb, as Nlrp3 and Casp-1 deficient 
mice did not exhibit reduced survival compared to wild-type mice in a mouse 
aerosol model infection.  The non-inflammasome forming NLR, NLRP12, is 
known to bind ASC (McConnell and Vertino, 2004).  NLRP12 has been shown to 
suppress cytokine production through inhibition of NFκB signaling in a human 
monocytic cell line following Mtb, LPS, and TNFα stimulation (Williams et al., 
2005).  We hypothesized that NLRP12 could also be playing an important role in 
host protection against Mtb through an interaction with ASC.  In contrast to this 
hypothesis, we found that Nlrp12 does not play a prominent role in host 
protection against Mtb, shown by survival and bacterial organ burden similar to 
wild-type mice.  Unexpectedly, Nlrp12 did not have an anti-inflammatory effect 
during Mtb infection.  In the absence of Nlrp12 we observed reduced TNFα and 
IL-6, indicating that Nlrp12 has an inflammatory effect during Mtb infection.  
Similar to our NLRP3 data, this underscores the importance of transitioning 
results found in cell culture into in vivo models of infection. 
 Our findings were not the first to indicate an inflammasome-independent 
role for ASC.  ASC has been associated with NFκB and AP1 signaling 
independent of NLRP3 or caspase-1 function (Hasegawa et al., 2009; Stehlik et 
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al., 2002; Taxman et al., 2006).  Recently a microbial pathogen-induced 
mechanism for ASC in activating chemokine expression through MAPK activation 
was discovered which occurred independent of the inflammasome (Taxman et. 
al, manuscript submitted).  Two recent reports have implicated a role for ASC in 
the absence of the inflammasome using in vivo models of arthritis, but they 
provide little mechanism to explain their findings (Ippagunta et al., 2010; Kolly et 
al., 2009).  Mechanistic insight gained while studying the role of ASC in the host 
response to Mtb may be informative for a myriad of chronic diseases.   
 We propose the following model to explain the reduced survival of ASC-/- 
mice following Mtb infection (Figure 4.1).  Through yet undescribed processes 
possibly involving changes in MAPK on NFκB signaling and chemokines 
regulation, ASC is involved in recruitment of CD11c+ CD11bmid/low to the 
granuloma where they play a role in granuloma structure.  In the absence of 
ASC, granuloma integrity is compromised and bacteria are not contained with the 
granulomas, but are instead spread throughout the lung.  Mtb outside of the 
granuloma mimics the initial stages of Mtb infection, a process during which 
GR1+ cells are recruited to the lung.  In wild-type mice, the number of GR1+ cells 
in the lung peak at two weeks postinfection after which the numbers recede.  In 
the case of the ASC-/- mice, GR1+ cells are continually recruited to the lung 
throughout the chronic phase of Mtb infection.  The antimicrobial functions of 
GR1+ cells can damage host cells as well pathogens (Smith, 1994).  It is possible 
that the constant influx of GR1+ cells into the lung causes extensive damage to 
the lung tissue, which could result in the premature death of ASC-/- mice.   
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Cellular composition of granulomas in ASC-/- and wild-type lungs 
 Our studies have identified an absent lung cell populations during chronic 
Mtb infection that correlates with reduced granulomas in the lung.  This suggests 
that the absent cell population may play a role in granuloma formation and/or 
maintenance during chronic Mtb infection.  Ultimately, it is important to determine 
what cells are present within the Mtb-induced granuloma.  Experiments are 
underway to determine the immune cell composition of ASC-/- and wild-type 
granulomas isolated from their surrounding environment.  To bypass the 
challenge of isolating granulomas from mouse lungs under BSL3 conditions, we 
are using an approach developed by our collaborator Dr. Matyas Sandor at the 
University of Wisconsin-Madison.  His method uses intra-perteritoneal (i.p.) 
delivery of the Mtb vaccine strain M. bovis BCG to induce the formation of liver 
granulomas.  The benefits of this model are the use of a BSL2 pathogen and the 
rapid formation of liver granulomas with the latest time point needed to be tested 
being 10 weeks postinjection.  Granulomas are isolated, disrupted, and the 
immune cell composition is identified by flow cytometry analysis.  We will use the 
same cell surface antibodies as were used in our whole lung digests—CD4 and 
CD8 to identify lymphocyte populations along with CD11b, CD11c, and F4/80 for 
monocyte-derived populations.  In addition, we will use LFA and CD40L, markers 
of T cell activation, as well as CD40, CD86/80, and MHC class II, activation 
markers on antigen-presenting cells.  We are optimistic that this experiment will 
identify differences in the immune cell composition between ASC-/- and wild-type 
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granulomas.  It is our hope that these data corroborate and expands upon our 
findings with whole lung digests and provide insights into differences in lung 
granulomas between ASC-/- and wild-type mice. 
  
Future studies 
 The future direction of this project involves the continued study of the 
lungs of ASC-/- mice to determine mechanisms by which ASC is impacting 
survival during chronic Mtb infection.  We have identified differences in the 
CD11c+ CD11bmid/low and GR1+ cell populations of ASC-/- lungs compared to wild-
type lungs.  To determine the immune cell composition of isolated granulomas, in 
contrast to the entire lung, we are isolating M. bovis BCG-induced liver 
granulomas and analyzing their immune cell composition through flow cytometry.  
To continue this project, we would confirm any findings in our liver granuloma 
model by isolating virulent Mtb-induced lung granulomas and analyzing their 
cellular composition. 
 Secondly, we want to identify cell signaling pathways that differ within the 
cells of ASC-/- and wild-type mice due to the inflammasome-independent role of 
ASC during chronic Mtb infection.  These experiments will allow us to better 
understand the mechanisms by which ASC protects the host during chronic Mtb 
infection.  There are several ways to identify expression differences in transcripts 
within granulomas of ASC-/- and wild-type mice.  Using laser capture microscopy, 
we could extract RNA from granulomatous tissue within paraffin-embedded lung 
tissue of Mtb-infected ASC-/- and wild-type mice.  RNA could then be quantified 
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by either real-time PCR or by microarray.  Alternatively, RNA could be isolated 
from liver granulomas for transcriptional analysis.  Identifying cytokine, 
chemokines, or cell signaling differences in ASC-/- mice may provide insight into 
the role of CD11c+ CD11bmid/low cells in ASC-/- lungs or clarify the role of ASC in 
granuloma formation.  Ultimately, they could aid us in understanding the role of 
ASC in host protection against Mtb infection. 
 
Summary 
 Our initial hypothesis was that the NLRP3 inflammasome would be 
activated by Mtb in cultured macrophages, and that activation would be 
dependent on NLRP3, ASC, and caspase-1.  Our hypothesis was correct in 
cultured macrophages and monocytes.  We believed that the NLRP3 
inflammasome would thus be important for host resistance to Mtb using an in 
vivo mouse model of infection.  We predicted that Nlrp3, ASC, and Casp-1 
deficient mice would result in reduced survival after Mtb infection due to 
decreased IL-1β within the lungs of the mice compared to wild-type.  In contrast 
to our hypothesis, we found that ASC alone was important for host protection 
during chronic Mtb infection while Nlrp3-/- and Casp-1-/- mice survived as long as 
wild-type mice.  In addition, cleaved IL-1β was present in the lungs of Nlrp3-/- , 
ASC-/-, and Casp-1-/- mice.  Identification of ASC as an important protein for host 
protection during Mtb infection—occurring independently of the inflammasome—
represents an unexpected and novel finding.  Although two other in vivo reports 
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from the arthritis field have identified an inflammasome-independent role for 
ASC, very little is known about the mechanism by which this occurs.   
 With high rates of Mtb infection worldwide and an increasing number drug 
resistant TB cases, it is our hope that increased understanding of the interaction 
between Mtb and the host immune system will lead to new and more effective 
anti-TB therapies.  Our data suggest that overexpression of ASC may lead to 
increased host protection against Mtb infection through increased granuloma 
stability and therefore through bacterial containment within granulomas.  We 
propose that this treatment could be used to prevent TB reactivation in 
immunocompromised individuals.   
 Also, the lack of a role for NLRP3 during an in vivo model of Mtb infection 
has important implications for treatment of autoinflammatory disorders.  The 
TNFα inhibitor Remicade is used to treat patients with arthritis, Crohns disease, 
ulcerative colitis, and other autoimmune diseases.  TNFα is important for 
granuloma maintenance in humans, and treatment with TNFα inhibitors often 
lead to reactivation of TB.  Our data suggests that NLRP3 could developed as a 
drug target to treat inflammatory diseases, and inhibition of NLRP3 is not likely to 
cause reactivation of TB as is the case with TNFα inhibitors. 
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FIGURES
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Figure 4.1.  Working model that demonstrates why ASC-/- mice are more 
susceptible to Mtb infection.  Figure adapted from New York Academy for 
Sciences© 
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